{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:21:00Z","timestamp":1790306460861,"version":"4.1.0"},"reference-count":384,"publisher":"American Association for the Advancement of Science (AAAS)","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473221"],"award-info":[{"award-number":["82473221"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272709"],"award-info":[{"award-number":["82272709"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072979"],"award-info":[{"award-number":["82072979"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2025AFB240"],"award-info":[{"award-number":["2025AFB240"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2022YFC2406100"],"award-info":[{"award-number":["2022YFC2406100"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503968"],"award-info":[{"award-number":["82503968"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["spj.science.org"],"crossmark-restriction":true},"short-container-title":["Research"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Alternative splicing (AS) is the central mechanism of transcriptional regulation and generates diverse splice variants that influence protein structure, function, and intracellular activity. AS plays critical roles in tissue differentiation, organ development, and disease progression. This review focuses on the pivotal roles of AS in bone biology, highlighting its regulatory effects on osteoblasts, osteoclasts, chondrocytes, bone matrix remodeling, and bone remodeling, as well as the involvement of AS-related RNA-binding proteins in these processes. We also emphasize bone-specific AS events and their physiological importance in skeletal development and maintenance. Furthermore, the pathological role of AS is emphasized in bone-related tumors such as osteosarcoma, Ewing sarcoma, and chondrosarcoma. This review also explores aberrant AS mechanisms in bone metastatic cancers, including prostate, bladder, and breast cancers, with an in-depth analysis of their roles in tumor progression and alterations in the bone microenvironment. This review provides a comprehensive perspective on how AS factors, signaling pathways, and mechanical stimulation collaboratively regulate bone cells under both physiological and pathological conditions, paving the way for identifying potential intervention strategies. The mechanisms of AS in other pathological bone conditions, such as osteoporosis, osteoarthritis, and hereditary bone disorders, are also summarized. The potential applications of targeting AS in the diagnosis and treatment of bone diseases are discussed, offering insights into the underlying mechanisms and clinical translational potential.<\/jats:p>","DOI":"10.34133\/research.0977","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T15:16:43Z","timestamp":1760455003000},"update-policy":"https:\/\/doi.org\/10.34133\/aaas_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Alternative Splicing: A Critical Regulator in Human Bone Biology and Tumor Progression"],"prefix":"10.34133","volume":"8","author":[{"given":"Li","family":"Cao","sequence":"first","affiliation":[{"name":"Department of Orthopaedic, Union Hospital, Tongji Medical College, \rHuazhong University of Science and Technology, Wuhan 430022, People\u2019s Republic of China."},{"name":"Division of Medical Oncology, Department of Medicine, \rWashington University School of Medicine, St. Louis, MO 63110, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic, Union Hospital, Tongji Medical College, \rHuazhong University of Science and Technology, Wuhan 430022, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic, Union Hospital, Tongji Medical College, \rHuazhong University of Science and Technology, Wuhan 430022, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A","family":"Ruiz-Cardozo","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Medicine, \rWashington University School of Medicine, St. Louis, MO 63110, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Medicine, \rWashington University School of Medicine, St. Louis, MO 63110, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Medicine, \rWashington University School of Medicine, St. Louis, MO 63110, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1616-8118","authenticated-orcid":true,"given":"Zengwu","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic, Union Hospital, Tongji Medical College, \rHuazhong University of Science and Technology, Wuhan 430022, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian Andrew","family":"Van Tine","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Medicine, \rWashington University School of Medicine, St. Louis, MO 63110, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic, Union Hospital, Tongji Medical College, \rHuazhong University of Science and Technology, Wuhan 430022, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(77)90180-5"},{"issue":"8","key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1073\/pnas.74.8.3171","article-title":"Spliced segments at the 5\u2019 terminus of adenovirus 2 late mRNA","volume":"74","author":"Berget SM","year":"1977","unstructured":"Berget SM, Moore C, Sharp PA. Spliced segments at the 5\u2019 terminus of adenovirus 2 late mRNA. Proc Natl Acad Sci USA. 1977;74(8):3171\u20133175.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"e_1_3_2_4_2","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4685-gmb-2023-0228","article-title":"Group I introns: Structure, splicing and their applications in medical mycology","volume":"47","author":"Gomes R","year":"2024","unstructured":"Gomes R, Silva K, Theodoro RC. Group I introns: Structure, splicing and their applications in medical mycology. Genet Mol Biol. 2024;47(Suppl 1): Article e20230228.","journal-title":"Genet Mol Biol"},{"issue":"11","key":"e_1_3_2_5_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2019.07.006","article-title":"Repeat-associated RNA structure and aberrant splicing","volume":"1862","author":"Hale MA","year":"2019","unstructured":"Hale MA, Johnson NE, Berglund JA. Repeat-associated RNA structure and aberrant splicing. Biochim Biophys Acta Gene Regul Mech. 2019;1862(11\u201312): Article 194405.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00541-7"},{"issue":"7","key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1515\/BC.2007.090","article-title":"Group II introns: Structure, folding and splicing mechanism","volume":"388","author":"Fedorova O","year":"2007","unstructured":"Fedorova O, Zingler N. Group II introns: Structure, folding and splicing mechanism. Biol Chem. 2007;388(7):665\u2013678.","journal-title":"Biol Chem"},{"issue":"1","key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0092-8674(81)90273-7","article-title":"Intranuclear location of the tRNA splicing enzymes","volume":"23","author":"De Robertis EM","year":"1981","unstructured":"De Robertis EM, Black P, Nishikura K. Intranuclear location of the tRNA splicing enzymes. Cell. 1981;23(1):89\u201393.","journal-title":"Cell"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12734"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2020.12.009"},{"issue":"5","key":"e_1_3_2_11_2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a032391","article-title":"Structural basis of nuclear pre-mRNA splicing: Lessons from yeast","volume":"11","author":"Plaschka C","year":"2019","unstructured":"Plaschka C, Newman AJ, Nagai K. Structural basis of nuclear pre-mRNA splicing: Lessons from yeast. Cold Spring Harb Perspect Biol. 2019;11(5): Article a032391.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41392-024-01734-2","article-title":"Alternative splicing and related RNA binding proteins in human health and disease","volume":"9","author":"Tao Y","year":"2024","unstructured":"Tao Y, Zhang Q, Wang H, Yang X, Mu H. Alternative splicing and related RNA binding proteins in human health and disease. Signal Transduct Target Ther. 2024;9(1):26.","journal-title":"Signal Transduct Target Ther"},{"issue":"21","key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.3390\/cells12212576","article-title":"A brief review of bone cell function and importance","volume":"12","author":"\u0160romov\u00e1 V","year":"2023","unstructured":"\u0160romov\u00e1 V, Sobola D, Kaspar P. A brief review of bone cell function and importance. Cells. 2023;12(21):2576.","journal-title":"Cells"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"1051192","DOI":"10.3389\/fgene.2023.1051192","article-title":"Genome-wide identification of alternative splicing and splicing regulated in immune infiltration in osteosarcoma patients","volume":"14","author":"Dai Z","year":"2023","unstructured":"Dai Z, Sun Y, Maihemuti M, Jiang R. Genome-wide identification of alternative splicing and splicing regulated in immune infiltration in osteosarcoma patients. Front Genet. 2023;14:1051192.","journal-title":"Front Genet"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110718","article-title":"Alternative splicing events and function in the tumor microenvironment: New opportunities and challenges","volume":"123","author":"Song X","year":"2023","unstructured":"Song X, Li X, Ge Y, Song J, Wei Q, He M, Wei M, Zhang Y, Chen T, Zhao L. Alternative splicing events and function in the tumor microenvironment: New opportunities and challenges. Int Immunopharmacol. 2023;123: Article 110718.","journal-title":"Int Immunopharmacol"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-022-00545-z"},{"issue":"1","key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-021-00486-7","article-title":"Alternative splicing and cancer: A systematic review","volume":"6","author":"Zhang Y","year":"2021","unstructured":"Zhang Y, Qian J, Gu C, Yang Y. Alternative splicing and cancer: A systematic review. Signal Transduct Target Ther. 2021;6(1):78.","journal-title":"Signal Transduct Target Ther"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239032"},{"issue":"1","key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41467-017-01241-9","article-title":"CryoEM structure of Saccharomyces cerevisiae U1 snRNP offers insight into alternative splicing","volume":"8","author":"Li X","year":"2017","unstructured":"Li X, Liu S, Jiang J, Zhang L, Espinosa S, Hill RC, Hansen KC, Zhou ZH, Zhao R. CryoEM structure of Saccharomyces cerevisiae U1 snRNP offers insight into alternative splicing. Nat Commun. 2017;8(1):1035.","journal-title":"Nat Commun"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau0325"},{"issue":"1","key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1038\/s41467-021-23459-4","article-title":"Activation of Prp28 ATPase by phosphorylated Npl3 at a critical step of spliceosome remodeling","volume":"12","author":"Yeh FL","year":"2021","unstructured":"Yeh FL, Chang SL, Ahmed GR, Liu HI, Tung L, Yeh CS, Lanier LS, Maeder C, Lin CM, Tsai SC, et al. Activation of Prp28 ATPase by phosphorylated Npl3 at a critical step of spliceosome remodeling. Nat Commun. 2021;12(1):3082.","journal-title":"Nat Commun"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041855"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.51"},{"issue":"1","key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13578-021-00581-w","article-title":"Regulatory roles and mechanisms of alternative RNA splicing in adipogenesis and human metabolic health","volume":"11","author":"Chao Y","year":"2021","unstructured":"Chao Y, Jiang Y, Zhong M, Wei K, Hu C, Qin Y, Zuo Y, Yang L, Shen Z, Zou C. Regulatory roles and mechanisms of alternative RNA splicing in adipogenesis and human metabolic health. Cell Biosci. 2021;11(1):66.","journal-title":"Cell Biosci"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2777"},{"issue":"1","key":"e_1_3_2_26_2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a032409","article-title":"Molecular mechanisms of pre-mRNA splicing through structural biology of the spliceosome","volume":"11","author":"Yan C","year":"2019","unstructured":"Yan C, Wan R, Shi Y. Molecular mechanisms of pre-mRNA splicing through structural biology of the spliceosome. Cold Spring Harb Perspect Biol. 2019;11(1): Article a032409.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1038\/s41467-024-50785-0","article-title":"Molecular basis for the activation of human spliceosome","volume":"15","author":"Zhan X","year":"2024","unstructured":"Zhan X, Lu Y, Shi Y. Molecular basis for the activation of human spliceosome. Nat Commun. 2024;15(1):6348.","journal-title":"Nat Commun"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tree.2021.11.010"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.3217705"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab1280"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2377"},{"issue":"1","key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1038\/s41467-020-16673-z","article-title":"Mutational bias and the protein code shape the evolution of splicing enhancers","volume":"11","author":"Rong S","year":"2020","unstructured":"Rong S, Buerer L, Rhine CL, Wang J, Cygan KJ, Fairbrother WG. Mutational bias and the protein code shape the evolution of splicing enhancers. Nat Commun. 2020;11(1):2845.","journal-title":"Nat Commun"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.10.13.1569"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrg775"},{"issue":"1","key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1897-4287-11-15","article-title":"Familial adenomatous polyposis of the colon","volume":"11","author":"Plawski A","year":"2013","unstructured":"Plawski A, Banasiewicz T, Borun P, Kubaszewski L, Krokowicz P, Skrzypczak-Zielinska M, Lubinski J. Familial adenomatous polyposis of the colon. Hered Cancer Clin Pract. 2013;11(1):15.","journal-title":"Hered Cancer Clin Pract"},{"issue":"12","key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1093\/nar\/gkm387","article-title":"PLP\/DM20 ratio is regulated by hnRNPH and F and a novel G-rich enhancer in oligodendrocytes","volume":"35","author":"Wang E","year":"2007","unstructured":"Wang E, Dimova N, Cambi F. PLP\/DM20 ratio is regulated by hnRNPH and F and a novel G-rich enhancer in oligodendrocytes. Nucleic Acids Res. 2007;35(12):4164\u20134178.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng858","article-title":"A new type of mutation causes a splicing defect in ATM","volume":"30","author":"Pagani F","year":"2002","unstructured":"Pagani F, Buratti E, Stuani C, Bendix R, D\u00f6rk T, Baralle FE. A new type of mutation causes a splicing defect in ATM. Nat Genet. 2002;30(4):426\u2013429.","journal-title":"Nat Genet"},{"issue":"8","key":"e_1_3_2_38_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023349","article-title":"Interaction of hnRNPA1\/A2 and DAZAP1 with an Alu-derived intronic splicing enhancer regulates ATM aberrant splicing","volume":"6","author":"Pastor T","year":"2011","unstructured":"Pastor T, Pagani F. Interaction of hnRNPA1\/A2 and DAZAP1 with an Alu-derived intronic splicing enhancer regulates ATM aberrant splicing. PLOS ONE. 2011;6(8): Article e23349.","journal-title":"PLOS ONE"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17010003"},{"issue":"46","key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"38297","DOI":"10.1074\/jbc.M508123200","article-title":"Differential expression of CD45 isoforms is controlled by the combined activity of basal and inducible splicing-regulatory elements in each of the variable exons","volume":"280","author":"Tong A","year":"2005","unstructured":"Tong A, Nguyen J, Lynch KW. Differential expression of CD45 isoforms is controlled by the combined activity of basal and inducible splicing-regulatory elements in each of the variable exons. J Biol Chem. 2005;280(46):38297\u201338304.","journal-title":"J Biol Chem"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600745"},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","unstructured":"Jez J. Encyclopedia of biological chemistry: Third edition. Amsterdam (Netherlands): Elsevier; 2021; 1-6:1-4822.","DOI":"10.1016\/B978-0-12-819460-7.09005-8"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3525"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2013.08.019"},{"issue":"10","key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/gb-2009-10-10-242","article-title":"The SR protein family","volume":"10","author":"Shepard PJ","year":"2009","unstructured":"Shepard PJ, Hertel KJ. The SR protein family. Genome Biol. 2009;10(10):242.","journal-title":"Genome Biol"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1042\/BST20210325"},{"issue":"1","key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s11658-024-00594-6","article-title":"SR proteins in cancer: Function, regulation, and small inhibitor","volume":"29","author":"Bei M","year":"2024","unstructured":"Bei M, Xu J. SR proteins in cancer: Function, regulation, and small inhibitor. Cell Mol Biol Lett. 2024;29(1):78.","journal-title":"Cell Mol Biol Lett"},{"issue":"14","key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1073\/pnas.0500543102","article-title":"Serine\/arginine-rich protein-dependent suppression of exon skipping by exonic splicing enhancers","volume":"102","author":"Ibrahim EC","year":"2005","unstructured":"Ibrahim EC, Schaal TD, Hertel KJ, Reed R, Maniatis T. Serine\/arginine-rich protein-dependent suppression of exon skipping by exonic splicing enhancers. Proc Natl Acad Sci USA. 2005;102(14):5002\u20135007.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6582","key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/381535a0","article-title":"Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA","volume":"381","author":"Kanopka A","year":"1996","unstructured":"Kanopka A, M\u00fchlemann O, Akusj\u00e4rvi G. Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA. Nature. 1996;381(6582):535\u2013538.","journal-title":"Nature"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3778"},{"issue":"2","key":"e_1_3_2_51_2","first-page":"85","article-title":"The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression","volume":"1765","author":"Carpenter B","year":"2006","unstructured":"Carpenter B, MacKay C, Alnabulsi A, MacKay M, Telfer C, Melvin WT, Murray GI. The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim Biophys Acta. 2006;1765(2):85\u2013100.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4161\/rna.7.1.10402","article-title":"HnRNP L-mediated regulation of mammalian alternative splicing by interference with splice site recognition","volume":"7","author":"Heiner M","year":"2010","unstructured":"Heiner M, Hui J, Schreiner S, Hung LH, Bindereif A. HnRNP L-mediated regulation of mammalian alternative splicing by interference with splice site recognition. RNA Biol. 2010;7(1):56\u201364.","journal-title":"RNA Biol"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.23.6.1874-1884.2003"},{"issue":"7","key":"e_1_3_2_54_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107414","article-title":"Splicing factor hnRNPA1 regulates alternative splicing of LOXL2 to enhance the production of LOXL2\u039413","volume":"300","author":"Pan D","year":"2024","unstructured":"Pan D, Long L, Li C, Zhou Y, Liu Q, Zhao Z, Zhao H, Lin W, Zheng Z, Peng L, et al. Splicing factor hnRNPA1 regulates alternative splicing of LOXL2 to enhance the production of LOXL2\u039413. J Biol Chem. 2024;300(7): Article 107414.","journal-title":"J Biol Chem"},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.biochi.2023.01.017","article-title":"Modular architecture and functional annotation of human RNA-binding proteins containing RNA recognition motif","volume":"209","author":"Agarwal A","year":"2023","unstructured":"Agarwal A, Bahadur RP. Modular architecture and functional annotation of human RNA-binding proteins containing RNA recognition motif. Biochimie. 2023;209:116\u2013130.","journal-title":"Biochimie"},{"issue":"1","key":"e_1_3_2_56_2","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1038\/s41467-023-39961-w","article-title":"Structural basis for specific RNA recognition by the alternative splicing factor RBM5","volume":"14","author":"Soni K","year":"2023","unstructured":"Soni K, Jagtap PKA, Mart\u00ednez-Lumbreras S, Bonnal S, Geerlof A, Stehle R, Simon B, Valcarcel J, Sattler M. Structural basis for specific RNA recognition by the alternative splicing factor RBM5. Nat Commun. 2023;14(1):4233.","journal-title":"Nat Commun"},{"issue":"19","key":"e_1_3_2_57_2","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1016\/j.molcel.2024.08.010","article-title":"Integrated multi-omics analysis of zinc-finger proteins uncovers roles in RNA regulation","volume":"84","author":"Gosztyla ML","year":"2024","unstructured":"Gosztyla ML, Zhan L, Olson S, Wei X, Naritomi J, Nguyen G, Street L, Goda GA, Cavazos FF, Schmok JC, et al. Integrated multi-omics analysis of zinc-finger proteins uncovers roles in RNA regulation. Mol Cell. 2024;84(19):3826\u201342.e8.","journal-title":"Mol Cell"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2017.01.011"},{"issue":"3","key":"e_1_3_2_59_2","first-page":"205","article-title":"KH-domain poly(C)-binding proteins as versatile regulators of multiple biological processes","volume":"84","author":"Nazarov IB","year":"2019","unstructured":"Nazarov IB, Bakhmet EI, Tomilin AN. KH-domain poly(C)-binding proteins as versatile regulators of multiple biological processes. Biochemistry. 2019;84(3):205\u2013219.","journal-title":"Biochemistry"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0246-y"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-022-00772-5"},{"issue":"12","key":"e_1_3_2_62_2","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/cells13121021","article-title":"Analysis of the TID-I and TID-L splice variants\u2019 expression profile under in\u00a0vitro differentiation of human mesenchymal bone marrow cells into osteoblasts","volume":"13","author":"Krakowian D","year":"2024","unstructured":"Krakowian D, Lesiak M, Augu\u015bciak-Duma A, Witecka J, Kusz D, Siero\u0144 AL, Gawron K. Analysis of the TID-I and TID-L splice variants\u2019 expression profile under in\u00a0vitro differentiation of human mesenchymal bone marrow cells into osteoblasts. Cells. 2024;13(12):1021.","journal-title":"Cells"},{"issue":"20","key":"e_1_3_2_63_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39334","article-title":"Filamin B knockdown impairs differentiation and function in mouse pre-osteoblasts via aberrant transcription and alternative splicing","volume":"10","author":"Wang X","year":"2024","unstructured":"Wang X, Jia Q, Yu L, Huang J, Wang X, Zhou L, Mijiti W, Dong S, Xie Z, Ma H. Filamin B knockdown impairs differentiation and function in mouse pre-osteoblasts via aberrant transcription and alternative splicing. Heliyon. 2024;10(20): Article e39334.","journal-title":"Heliyon"},{"issue":"4","key":"e_1_3_2_64_2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.bbrc.2015.12.003","article-title":"Target disruption of ribosomal protein pNO40 accelerates aging and impairs osteogenic differentiation of mesenchymal stem cells","volume":"469","author":"Lin YM","year":"2016","unstructured":"Lin YM, Wu CC, Chang YC, Wu CH, Ho HL, Hu JW, Chang RC, Wang CT, Ouyang P. Target disruption of ribosomal protein pNO40 accelerates aging and impairs osteogenic differentiation of mesenchymal stem cells. Biochem Biophys Res Commun. 2016;469(4):903\u2013910.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"e_1_3_2_65_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074799","article-title":"Alternative splicing targeting the hTAF4-TAFH domain of TAF4 represses proliferation and accelerates chondrogenic differentiation of human mesenchymal stem cells","volume":"8","author":"Kazantseva J","year":"2013","unstructured":"Kazantseva J, Kivil A, Tints K, Kazantseva A, Neuman T, Palm K. Alternative splicing targeting the hTAF4-TAFH domain of TAF4 represses proliferation and accelerates chondrogenic differentiation of human mesenchymal stem cells. PLOS ONE. 2013;8(10): Article e74799.","journal-title":"PLOS ONE"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030551"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-023-10559-5"},{"issue":"7","key":"e_1_3_2_68_2","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/jbmr.2814","article-title":"Cbfb2 isoform dominates more potent Cbfb1 and is required for skeletal development","volume":"31","author":"Jiang Q","year":"2016","unstructured":"Jiang Q, Qin X, Kawane T, Komori H, Matsuo Y, Taniuchi I, Ito K, Izumi SI, Komori T. Cbfb2 isoform dominates more potent Cbfb1 and is required for skeletal development. J Bone Miner Res. 2016;31(7):1391\u20131404.","journal-title":"J Bone Miner Res"},{"key":"e_1_3_2_69_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bone.2018.04.006","article-title":"Transcriptional profiling of murine osteoblast differentiation based on RNA-seq expression analyses","volume":"113","author":"Khayal LA","year":"2018","unstructured":"Khayal LA, Gr\u00fcnhagen J, Provazn\u00edk I, Mundlos S, Kornak U, Robinson PN, Ott C-E. Transcriptional profiling of murine osteoblast differentiation based on RNA-seq expression analyses. Bone. 2018;113:29\u201340.","journal-title":"Bone"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1177\/0022034515622443"},{"issue":"3","key":"e_1_3_2_71_2","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1210\/en.2009-1217","article-title":"Minireview: Mechano-growth factor: A putative product of IGF-I gene expression involved in tissue repair and regeneration","volume":"151","author":"Matheny RW","year":"2010","unstructured":"Matheny RW Jr, Nindl BC, Adamo ML. Minireview: Mechano-growth factor: A putative product of IGF-I gene expression involved in tissue repair and regeneration. Endocrinology. 2010;151(3):865\u2013875.","journal-title":"Endocrinology"},{"issue":"1","key":"e_1_3_2_72_2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1113\/jphysiol.2002.032136","article-title":"Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise","volume":"547","author":"Hameed M","year":"2003","unstructured":"Hameed M, Orrell RW, Cobbold M, Goldspink G, Harridge SD. Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. J Physiol. 2003;547(Pt 1):247\u2013254.","journal-title":"J Physiol"},{"issue":"1","key":"e_1_3_2_73_2","first-page":"322","article-title":"Splicing factor-modulated generation of mechano growth factor regulates physiological processes in osteoblasts under mechanical stimuli","volume":"13","author":"Yi Q","year":"2019","unstructured":"Yi Q, Liu H, Feng J, Wu Y, Sun W, Ou M, Tang L. Splicing factor-modulated generation of mechano growth factor regulates physiological processes in osteoblasts under mechanical stimuli. Cell Adhes Migr. 2019;13(1):322\u2013331.","journal-title":"Cell Adhes Migr"},{"issue":"2","key":"e_1_3_2_74_2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/genes12020306","article-title":"BAF57\/SMARCE1 interacting with splicing factor SRSF1 regulates mechanical stress-induced alternative splicing of cyclin D1","volume":"12","author":"Feng J","year":"2021","unstructured":"Feng J, Xu X, Fan X, Yi Q, Tang L. BAF57\/SMARCE1 interacting with splicing factor SRSF1 regulates mechanical stress-induced alternative splicing of cyclin D1. Genes. 2021;12(2):306.","journal-title":"Genes"},{"issue":"1","key":"e_1_3_2_75_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11154-006-9001-5","article-title":"Networks and hubs for the transcriptional control of osteoblastogenesis","volume":"7","author":"Lian JB","year":"2006","unstructured":"Lian JB, Stein GS, Javed A, van Wijnen AJ, Stein JL, Montecino M, Hassan MQ, Gaur T, Lengner CJ, Young DW. Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord. 2006;7(1-2):1\u201316.","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"e_1_3_2_76_2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1152\/physrev.1996.76.2.593","article-title":"Transcriptional control of osteoblast growth and differentiation","volume":"76","author":"Stein GS","year":"1996","unstructured":"Stein GS, Lian JB, Stein JL, Van Wijnen AJ, Montecino M. Transcriptional control of osteoblast growth and differentiation. Physiol Rev. 1996;76(2):593\u2013629.","journal-title":"Physiol Rev"},{"issue":"6","key":"e_1_3_2_77_2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00223-018-0462-9","article-title":"VWC2 increases bone formation through inhibiting Activin signaling","volume":"103","author":"Almehmadi A","year":"2018","unstructured":"Almehmadi A, Ohyama Y, Kaku M, Alamoudi A, Husein D, Katafuchi M, Mishina Y, Mochida Y. VWC2 increases bone formation through inhibiting Activin signaling. Calcif Tissue Int. 2018;103(6):663\u2013674.","journal-title":"Calcif Tissue Int"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2011.12.075"},{"issue":"4","key":"e_1_3_2_79_2","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31197","article-title":"The RNA-binding protein Cpeb4 regulates splicing of the Id2 gene in osteoclast differentiation","volume":"239","author":"Arasaki Y","year":"2024","unstructured":"Arasaki Y, Hayata T. The RNA-binding protein Cpeb4 regulates splicing of the Id2 gene in osteoclast differentiation. J Cell Physiol. 2024;239(4): Article e31197.","journal-title":"J Cell Physiol"},{"issue":"2","key":"e_1_3_2_80_2","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.684","article-title":"Splicing factor arginine\/serine-rich 8 promotes multiple myeloma malignancy and bone lesion through alternative splicing of CACYBP and exosome-based cellular communication","volume":"12","author":"Zhang Y","year":"2022","unstructured":"Zhang Y, Yu X, Sun R, Min J, Tang X, Lin Z, Xie S, Li X, Lu S, Tian Z, et al. Splicing factor arginine\/serine-rich 8 promotes multiple myeloma malignancy and bone lesion through alternative splicing of CACYBP and exosome-based cellular communication. Clin Transl Med. 2022;12(2): Article e684.","journal-title":"Clin Transl Med"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-010-0679-z"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-022-00792-w"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-024-01157-7"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2004.08.019"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M007104200"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(02)00685-3"},{"issue":"45","key":"e_1_3_2_87_2","doi-asserted-by":"crossref","first-page":"44273","DOI":"10.1074\/jbc.M303933200","article-title":"Expression of a structurally unique osteoclastic protein-tyrosine phosphatase is driven by an alternative intronic, cell type-specific promoter","volume":"278","author":"Amoui M","year":"2003","unstructured":"Amoui M, Baylink DJ, Tillman JB, Lau KH. Expression of a structurally unique osteoclastic protein-tyrosine phosphatase is driven by an alternative intronic, cell type-specific promoter. J Biol Chem. 2003;278(45):44273\u201344280.","journal-title":"J Biol Chem"},{"issue":"9","key":"e_1_3_2_88_2","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3390\/biom11091386","article-title":"Galectins in endothelial cell biology and angiogenesis: The basics","volume":"11","author":"Thijssen VL","year":"2021","unstructured":"Thijssen VL. Galectins in endothelial cell biology and angiogenesis: The basics. Biomolecules. 2021;11(9):1386.","journal-title":"Biomolecules"},{"issue":"1","key":"e_1_3_2_89_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/biom14010121","article-title":"Reduced form of Galectin-1 suppresses osteoclastic differentiation of human peripheral blood mononuclear cells and murine RAW264 cells in\u00a0vitro","volume":"14","author":"Takeuchi T","year":"2024","unstructured":"Takeuchi T, Oyama M, Tamura M, Arata Y, Hatanaka T. Reduced form of Galectin-1 suppresses osteoclastic differentiation of human peripheral blood mononuclear cells and murine RAW264 cells in\u00a0vitro. Biomolecules. 2024;14(1):121.","journal-title":"Biomolecules"},{"issue":"5","key":"e_1_3_2_90_2","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302348","article-title":"Galectin-8 modulates human osteoclast activity partly through isoform-specific interactions","volume":"7","author":"Roy M","year":"2024","unstructured":"Roy M, Mbous Nguimbus L, Badiane PY, Goguen-Couture V, Degrandmaison J, Parent JL, Brunet MA, Roux S. Galectin-8 modulates human osteoclast activity partly through isoform-specific interactions. Life Sci Alliance. 2024;7(5): Article e202302348.","journal-title":"Life Sci Alliance"},{"issue":"10","key":"e_1_3_2_91_2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/glycob\/cwu054","article-title":"Galectin-8: A matricellular lectin with key roles in angiogenesis","volume":"24","author":"Troncoso MF","year":"2014","unstructured":"Troncoso MF, Ferragut F, Bacigalupo ML, C\u00e1rdenas Delgado VM, Nugnes LG, Gentilini L, Laderach D, Wolfenstein-Todel C, Compagno D, Rabinovich GA, et al. Galectin-8: A matricellular lectin with key roles in angiogenesis. Glycobiology. 2014;24(10):907\u2013914.","journal-title":"Glycobiology"},{"issue":"7","key":"e_1_3_2_92_2","first-page":"1942","article-title":"Biomechanics of chondrocytes and chondrons in healthy conditions and osteoarthritis: A review of the mechanical characterisations at the microscale","volume":"11","author":"Pettenuzzo S","year":"2023","unstructured":"Pettenuzzo S, Arduino A, Belluzzi E, Pozzuoli A, Fontanella CG, Ruggieri P, Salomoni V, Majorana C, Berardo A. Biomechanics of chondrocytes and chondrons in healthy conditions and osteoarthritis: A review of the mechanical characterisations at the microscale. Biomedicine. 2023;11(7):1942.","journal-title":"Biomedicine"},{"key":"e_1_3_2_93_2","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.664168","article-title":"Molecular mechanisms of chondrocyte proliferation and differentiation","volume":"9","author":"Chen H","year":"2021","unstructured":"Chen H, Tan XN, Hu S, Liu RQ, Peng LH, Li YM, Wu P. Molecular mechanisms of chondrocyte proliferation and differentiation. Front Cell Dev Biol. 2021;9: Article 664168.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"e_1_3_2_94_2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/j.1742-4658.2007.05709.x","article-title":"Expression and physiological role of CCN4\/Wnt-induced secreted protein 1 mRNA splicing variants in chondrocytes","volume":"274","author":"Yanagita T","year":"2007","unstructured":"Yanagita T, Kubota S, Kawaki H, Kawata K, Kondo S, Takano-Yamamoto T, Tanaka S, Takigawa M. Expression and physiological role of CCN4\/Wnt-induced secreted protein 1 mRNA splicing variants in chondrocytes. FEBS J. 2007;274(7):1655\u20131665.","journal-title":"FEBS J"},{"issue":"4","key":"e_1_3_2_95_2","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201212RR","article-title":"Adenosine A2A receptor activation reduces chondrocyte senescence","volume":"37","author":"Friedman B","year":"2023","unstructured":"Friedman B, Larranaga-Vera A, Castro CM, Corciulo C, Rabbani P, Cronstein BN. Adenosine A2A receptor activation reduces chondrocyte senescence. FASEB J. 2023;37(4): Article e22838.","journal-title":"FASEB J"},{"issue":"7","key":"e_1_3_2_96_2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41419-018-0767-7","article-title":"\u0394133p53\u03b1, a natural p53 isoform, contributes to conditional reprogramming and long-term proliferation of primary epithelial cells","volume":"9","author":"Mondal AM","year":"2018","unstructured":"Mondal AM, Zhou H, Horikawa I, Suprynowicz FA, Li G, Dakic A, Rosenhal B, Ye L, Harris CC, Schlegel R, et al. \u0394133p53\u03b1, a natural p53 isoform, contributes to conditional reprogramming and long-term proliferation of primary epithelial cells. Cell Death Dis. 2018;9(7):750.","journal-title":"Cell Death Dis"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2010.91"},{"issue":"3","key":"e_1_3_2_98_2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.bbagen.2017.11.017","article-title":"Human IGF-I propeptide a promotes articular chondrocyte biosynthesis and employs glycosylation-dependent heparin binding","volume":"1862","author":"Shi S","year":"2018","unstructured":"Shi S, Kelly BJ, Wang C, Klingler K, Chan A, Eckert GJ, Trippel SB. Human IGF-I propeptide a promotes articular chondrocyte biosynthesis and employs glycosylation-dependent heparin binding. Biochim Biophys Acta Gen Subj. 2018;1862(3):567\u2013575.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"e_1_3_2_99_2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fendo.2013.00042","article-title":"New modulators for IGF-I activity within IGF-I processing products","volume":"4","author":"Brisson BK","year":"2013","unstructured":"Brisson BK, Barton ER. New modulators for IGF-I activity within IGF-I processing products. Front Endocrinol. 2013;4:42.","journal-title":"Front Endocrinol"},{"issue":"1","key":"e_1_3_2_100_2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.joca.2010.10.008","article-title":"Effects of TGF-\u03b21 on alternative splicing of superficial zone protein in articular cartilage cultures","volume":"19","author":"DuRaine GD","year":"2011","unstructured":"DuRaine GD, Chan SM, Reddi AH. Effects of TGF-\u03b21 on alternative splicing of superficial zone protein in articular cartilage cultures. Osteoarthr Cartil. 2011;19(1):103\u2013110.","journal-title":"Osteoarthr Cartil"},{"issue":"20","key":"e_1_3_2_101_2","doi-asserted-by":"crossref","first-page":"e2307442","DOI":"10.1002\/advs.202307442","article-title":"Circular RNA Gtdc1 protects against offspring osteoarthritis induced by prenatal prednisone exposure by regulating SRSF1-Fn1 signaling","volume":"11","author":"Liu L","year":"2024","unstructured":"Liu L, Hong Y, Ma C, Zhang F, Li Q, Li B, He H, Zhu J, Wang H, Chen L. Circular RNA Gtdc1 protects against offspring osteoarthritis induced by prenatal prednisone exposure by regulating SRSF1-Fn1 signaling. Adv Sci. 2024;11(20):e2307442.","journal-title":"Adv Sci"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.3109\/03008207.2014.908860"},{"issue":"5","key":"e_1_3_2_103_2","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/jcmm.17187","article-title":"A novel missense mutation of COL2A1 gene in a large family with stickler syndrome type I","volume":"26","author":"Liu X","year":"2022","unstructured":"Liu X, Dong H, Gong Y, Wang L, Zhang R, Zheng T, Zheng Y, Shen S, Zheng C, Tian M, et al. A novel missense mutation of COL2A1 gene in a large family with stickler syndrome type I. J Cell Mol Med. 2022;26(5):1530\u20131539.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"e_1_3_2_104_2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.matbio.2007.10.002","article-title":"Expression of two novel alternatively spliced COL2A1 isoforms during chondrocyte differentiation","volume":"27","author":"McAlinden A","year":"2008","unstructured":"McAlinden A, Johnstone B, Kollar J, Kazmi N, Hering TM. Expression of two novel alternatively spliced COL2A1 isoforms during chondrocyte differentiation. Matrix Biol. 2008;27(3):254\u2013266.","journal-title":"Matrix Biol"},{"key":"e_1_3_2_105_2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.matbio.2014.04.004","article-title":"Changes in type II procollagen isoform expression during chondrogenesis by disruption of an alternative 5\u2019 splice site within Col2a1 exon 2","volume":"36","author":"Hering TM","year":"2014","unstructured":"Hering TM, Wirthlin L, Ravindran S, McAlinden A. Changes in type II procollagen isoform expression during chondrogenesis by disruption of an alternative 5\u2019 splice site within Col2a1 exon 2. Matrix Biol. 2014;36:51\u201363.","journal-title":"Matrix Biol"},{"issue":"8","key":"e_1_3_2_106_2","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.yexcr.2007.01.028","article-title":"Transforming growth factor-beta1 regulates fibronectin isoform expression and splicing factor SRp40 expression during ATDC5 chondrogenic maturation","volume":"313","author":"Han F","year":"2007","unstructured":"Han F, Gilbert JR, Harrison G, Adams CS, Freeman T, Tao Z, Zaka R, Liang H, Williams C, Tuan RS, et al. Transforming growth factor-beta1 regulates fibronectin isoform expression and splicing factor SRp40 expression during ATDC5 chondrogenic maturation. Exp Cell Res. 2007;313(8):1518\u20131532.","journal-title":"Exp Cell Res"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-024-00624-0"},{"issue":"2","key":"e_1_3_2_108_2","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/rheumatology\/keac272","article-title":"Identification and functional characterization of imbalanced osteoarthritis-associated fibronectin splice variants","volume":"62","author":"Hoolwerff M","year":"2023","unstructured":"van Hoolwerff M, Tuerlings M, Wijnen IJL, Suchiman HED, Cats D, Mei H, Nelissen RGHH, van der Linden-van der Zwaag HMJ, Ramos YFM, de Almeida RC, et al. Identification and functional characterization of imbalanced osteoarthritis-associated fibronectin splice variants. Rheumatology (Oxford). 2023;62(2):894\u2013904.","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_3_2_109_2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3389\/fphar.2020.00757","article-title":"The bone extracellular matrix in bone formation and regeneration","volume":"11","author":"Lin X","year":"2020","unstructured":"Lin X, Patil S, Gao YG, Qian A. The bone extracellular matrix in bone formation and regeneration. Front Pharmacol. 2020;11:757.","journal-title":"Front Pharmacol"},{"key":"e_1_3_2_110_2","doi-asserted-by":"crossref","first-page":"9893131","DOI":"10.34133\/2021\/9893131","article-title":"Abnormal aggregation of invasive cancer cells induced by collective polarization and ECM-mediated mechanical coupling in coculture systems","volume":"2021","author":"Wang X","year":"2021","unstructured":"Wang X, Chen S, Nan H, Liu R, Ding Y, Song K, Shuai J, Fan Q, Zheng Y, Ye F, et al. Abnormal aggregation of invasive cancer cells induced by collective polarization and ECM-mediated mechanical coupling in coculture systems. Research. 2021;2021:9893131.","journal-title":"Research"},{"issue":"1","key":"e_1_3_2_111_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41413-022-00223-y","article-title":"Biomechanics and mechanobiology of the bone matrix","volume":"10","author":"Ma C","year":"2022","unstructured":"Ma C, Du T, Niu X, Fan Y. Biomechanics and mechanobiology of the bone matrix. Bone Res. 2022;10(1):59.","journal-title":"Bone Res"},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2016.02.003"},{"issue":"2","key":"e_1_3_2_113_2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0039-6257(02)00460-5","article-title":"Clinical variability of stickler syndrome: Role of exon 2 of the collagen COL2A1 gene","volume":"48","author":"Donoso LA","year":"2003","unstructured":"Donoso LA, Edwards AO, Frost AT, Ritter R III, Ahmad N, Vrabec T, Rogers J, Meyer D, Parma S. Clinical variability of stickler syndrome: Role of exon 2 of the collagen COL2A1 gene. Surv Ophthalmol. 2003;48(2):191\u2013203.","journal-title":"Surv Ophthalmol"},{"key":"e_1_3_2_114_2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.matbio.2013.09.001","article-title":"A unique tool to selectively detect the chondrogenic IIB form of human type II procollagen protein","volume":"34","author":"Aubert-Foucher E","year":"2014","unstructured":"Aubert-Foucher E, Mayer N, Pasdeloup M, Pagnon A, Hartmann D, Mallein-Gerin F. A unique tool to selectively detect the chondrogenic IIB form of human type II procollagen protein. Matrix Biol. 2014;34:80\u201388.","journal-title":"Matrix Biol"},{"issue":"3","key":"e_1_3_2_115_2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.matbio.2011.12.004","article-title":"Disruption of the developmentally-regulated Col2a1 pre-mRNA alternative splicing switch in a transgenic knock-in mouse model","volume":"31","author":"Lewis R","year":"2012","unstructured":"Lewis R, Ravindran S, Wirthlin L, Traeger G, Fernandes RJ, McAlinden A. Disruption of the developmentally-regulated Col2a1 pre-mRNA alternative splicing switch in a transgenic knock-in mouse model. Matrix Biol. 2012;31(3):214\u2013226.","journal-title":"Matrix Biol"},{"key":"e_1_3_2_116_2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.matbio.2013.10.014","article-title":"Characterization of a murine type IIB procollagen-specific antibody","volume":"34","author":"Patra D","year":"2014","unstructured":"Patra D, DeLassus E, McAlinden A, Sandell LJ. Characterization of a murine type IIB procollagen-specific antibody. Matrix Biol. 2014;34:154\u2013160.","journal-title":"Matrix Biol"},{"issue":"7","key":"e_1_3_2_117_2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.matbio.2012.08.002","article-title":"Quantification of type II procollagen splice forms using alternative transcript-qPCR (AT-qPCR)","volume":"31","author":"McAlinden A","year":"2012","unstructured":"McAlinden A, Shim KH, Wirthlin L, Ravindran S, Hering TM. Quantification of type II procollagen splice forms using alternative transcript-qPCR (AT-qPCR). Matrix Biol. 2012;31(7\u20138):412\u2013420.","journal-title":"Matrix Biol"},{"issue":"3","key":"e_1_3_2_118_2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.biocel.2010.12.010","article-title":"The matrilins: Modulators of extracellular matrix assembly","volume":"43","author":"Klatt AR","year":"2011","unstructured":"Klatt AR, Becker AK, Neacsu CD, Paulsson M, Wagener R. The matrilins: Modulators of extracellular matrix assembly. Int J Biochem Cell Biol. 2011;43(3):320\u2013330.","journal-title":"Int J Biochem Cell Biol"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2012.1056"},{"issue":"1","key":"e_1_3_2_120_2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41413-022-00219-8","article-title":"Bone remodeling: An operational process ensuring survival and bone mechanical competence","volume":"10","author":"Bolamperti S","year":"2022","unstructured":"Bolamperti S, Villa I, Rubinacci A. Bone remodeling: An operational process ensuring survival and bone mechanical competence. Bone Res. 2022;10(1):48.","journal-title":"Bone Res"},{"key":"e_1_3_2_121_2","doi-asserted-by":"publisher","DOI":"10.34133\/research.0447"},{"issue":"1","key":"e_1_3_2_122_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13046-018-1001-2","article-title":"RANKL\/RANK\/OPG system beyond bone remodeling: Involvement in breast cancer and clinical perspectives","volume":"38","author":"Infante M","year":"2019","unstructured":"Infante M, Fabi A, Cognetti F, Gorini S, Caprio M, Fabbri A. RANKL\/RANK\/OPG system beyond bone remodeling: Involvement in breast cancer and clinical perspectives. J Exp Clin Cancer Res. 2019;38(1):12.","journal-title":"J Exp Clin Cancer Res"},{"key":"e_1_3_2_123_2","doi-asserted-by":"crossref","first-page":"6910312","DOI":"10.1155\/2020\/6910312","article-title":"RANKL\/RANK\/OPG pathway: A mechanism involved in exercise-induced bone remodeling","volume":"2020","author":"Tobeiha M","year":"2020","unstructured":"Tobeiha M, Moghadasian MH, Amin N, Jafarnejad S. RANKL\/RANK\/OPG pathway: A mechanism involved in exercise-induced bone remodeling. Biomed Res Int. 2020;2020:6910312.","journal-title":"Biomed Res Int"},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2008.03.018"},{"key":"e_1_3_2_125_2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bone.2016.08.016","article-title":"Parathyroid hormone induces expression and proteolytic processing of Rankl in primary murine osteoblasts","volume":"92","author":"Heckt T","year":"2016","unstructured":"Heckt T, Keller J, Peters S, Streichert T, Chalaris A, Rose-John S, Mell B, Joe B, Aming M, Schinke T. Parathyroid hormone induces expression and proteolytic processing of Rankl in primary murine osteoblasts. Bone. 2016;92:85\u201393.","journal-title":"Bone"},{"key":"e_1_3_2_126_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116353","article-title":"RANKL biology","volume":"159","author":"Takegahara N","year":"2022","unstructured":"Takegahara N, Kim H, Choi Y. RANKL biology. Bone. 2022;159: Article 116353.","journal-title":"Bone"},{"issue":"1","key":"e_1_3_2_127_2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12178-009-9046-7","article-title":"RANK, RANKL and osteoprotegerin in bone biology and disease","volume":"2","author":"Wright HL","year":"2009","unstructured":"Wright HL, McCarthy HS, Middleton J, Marshall MJ. RANK, RANKL and osteoprotegerin in bone biology and disease. Curr Rev Musculoskelet Med. 2009;2(1):56\u201364.","journal-title":"Curr Rev Musculoskelet Med"},{"issue":"4","key":"e_1_3_2_128_2","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1210\/endo.142.4.8070","article-title":"Determination of three isoforms of the receptor activator of nuclear factor-kappaB ligand and their differential expression in bone and thymus","volume":"142","author":"Ikeda T","year":"2001","unstructured":"Ikeda T, Kasai M, Utsuyama M, Hirokawa K. Determination of three isoforms of the receptor activator of nuclear factor-kappaB ligand and their differential expression in bone and thymus. Endocrinology. 2001;142(4):1419\u20131426.","journal-title":"Endocrinology"},{"issue":"50","key":"e_1_3_2_129_2","doi-asserted-by":"crossref","first-page":"41700","DOI":"10.1074\/jbc.M507000200","article-title":"Identification of an alternatively spliced variant of Ca2+- promoted Ras inactivator as a possible regulator of RANKL shedding","volume":"280","author":"Hikita A","year":"2005","unstructured":"Hikita A, Kadono Y, Chikuda H, Fukuda A, Wakeyama H, Yasuda H, Nakamura K, Oda H, Miyazaki T, Tanaka S. Identification of an alternatively spliced variant of Ca2+- promoted Ras inactivator as a possible regulator of RANKL shedding. J Biol Chem. 2005;280(50):41700\u201341706.","journal-title":"J Biol Chem"},{"issue":"4","key":"e_1_3_2_130_2","doi-asserted-by":"crossref","first-page":"R112","DOI":"10.1186\/bcr3234","article-title":"Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: Implications in breast cancer cell survival and migration","volume":"14","author":"Papanastasiou AD","year":"2012","unstructured":"Papanastasiou AD, Sirinian C, Kalofonos HP. Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: Implications in breast cancer cell survival and migration. Breast Cancer Res. 2012;14(4):R112.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"e_1_3_2_131_2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.gene.2013.04.075","article-title":"Alternative splicing generates a truncated isoform of human TNFRSF11A (RANK) with an altered capacity to activate NF-\u03baB","volume":"525","author":"Sirinian C","year":"2013","unstructured":"Sirinian C, Papanastasiou AD, Zarkadis IK, Kalofonos HP. Alternative splicing generates a truncated isoform of human TNFRSF11A (RANK) with an altered capacity to activate NF-\u03baB. Gene. 2013;525(1):124\u2013129.","journal-title":"Gene"},{"issue":"3","key":"e_1_3_2_132_2","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3390\/ijms26030932","article-title":"Periostin splice variant expression in human osteoblasts from osteoporotic patients and its effects on interleukin-6 and osteoprotegerin","volume":"26","author":"Kuebart T","year":"2025","unstructured":"Kuebart T, Oezel L, G\u00fcrsoy B, Maus U, Windolf J, Bittersohl B, Grotheer V. Periostin splice variant expression in human osteoblasts from osteoporotic patients and its effects on interleukin-6 and osteoprotegerin. Int J Mol Sci. 2025;26(3):932.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_2_133_2","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.27192","article-title":"Extensive alternative splicing transitions during postnatal skeletal muscle development are required for calcium handling functions","volume":"6","author":"Brinegar AE","year":"2017","unstructured":"Brinegar AE, Xia Z, Loehr JA, Li W, Rodney GG, Cooper TA. Extensive alternative splicing transitions during postnatal skeletal muscle development are required for calcium handling functions. eLife. 2017;6: Article e27192.","journal-title":"eLife"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-185X.2009.00090.x"},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4020-6191-2_21"},{"key":"e_1_3_2_136_2","doi-asserted-by":"crossref","first-page":"1450328","DOI":"10.3389\/fendo.2024.1450328","article-title":"The role of calcium channels in osteoporosis and their therapeutic potential","volume":"15","author":"Hao Y","year":"2024","unstructured":"Hao Y, Yang N, Sun M, Yang S, Chen X. The role of calcium channels in osteoporosis and their therapeutic potential. Front Endocrinol. 2024;15:1450328.","journal-title":"Front Endocrinol"},{"key":"e_1_3_2_137_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-031620-091043"},{"key":"e_1_3_2_138_2","doi-asserted-by":"crossref","unstructured":"Striessnig J Nakao A Mori Y. Voltage-gated Ca2+ channels. Lessons from knockout and knock-in mice. In: Zamponi GW Weiss N editors. Voltage-gated calcium channels. Cham: Springer International Publishing; 2022. p. 255\u2013357.","DOI":"10.1007\/978-3-031-08881-0_11"},{"key":"e_1_3_2_139_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2004.09.011"},{"key":"e_1_3_2_140_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15299"},{"issue":"6","key":"e_1_3_2_141_2","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1124\/mol.110.063636","article-title":"Genetic and functional analysis of human P2X5 reveals a distinct pattern of exon 10 polymorphism with predominant expression of the nonfunctional receptor isoform","volume":"77","author":"Kotnis S","year":"2010","unstructured":"Kotnis S, Bingham B, Vasilyev DV, Miller SW, Bai Y, Yeola S, Chanda PK, Bowlby MR, Kaftan EJ, Samad TA, et al. Genetic and functional analysis of human P2X5 reveals a distinct pattern of exon 10 polymorphism with predominant expression of the nonfunctional receptor isoform. Mol Pharmacol. 2010;77(6):953\u2013960.","journal-title":"Mol Pharmacol"},{"key":"e_1_3_2_142_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M606113200"},{"issue":"9","key":"e_1_3_2_143_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104692","article-title":"A truncation variant of the cation channel P2RX5 is upregulated during T cell activation","volume":"9","author":"Abramowski P","year":"2014","unstructured":"Abramowski P, Ogrodowczyk C, Martin R, Pongs O. A truncation variant of the cation channel P2RX5 is upregulated during T cell activation. PLOS ONE. 2014;9(9): Article e104692.","journal-title":"PLOS ONE"},{"issue":"1","key":"e_1_3_2_144_2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41413-021-00168-8","article-title":"Roles of mechanosensitive channel Piezo1\/2 proteins in skeleton and other tissues","volume":"9","author":"Qin L","year":"2021","unstructured":"Qin L, He T, Chen S, Yang D, Yi W, Cao H, Xiao G. Roles of mechanosensitive channel Piezo1\/2 proteins in skeleton and other tissues. Bone Res. 2021;9(1):44.","journal-title":"Bone Res"},{"key":"e_1_3_2_145_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.11.035"},{"key":"e_1_3_2_146_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2020.02.010"},{"issue":"6","key":"e_1_3_2_147_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066883","article-title":"Evaluating the impact of sequencing depth on transcriptome profiling in human adipose","volume":"8","author":"Liu Y","year":"2013","unstructured":"Liu Y, Ferguson JF, Xue C, Silverman IM, Gregory B, Reilly MP, Li M. Evaluating the impact of sequencing depth on transcriptome profiling in human adipose. PLOS ONE. 2013;8(6): Article e66883.","journal-title":"PLOS ONE"},{"issue":"5","key":"e_1_3_2_148_2","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.210387","article-title":"A novel methodological approach to simultaneously extract high-quality total RNA and proteins from cortical and trabecular bone","volume":"12","author":"Faraldi M","year":"2022","unstructured":"Faraldi M, Mangiavini L, Conte C, Banfi G, Napoli N, Lombardi G. A novel methodological approach to simultaneously extract high-quality total RNA and proteins from cortical and trabecular bone. Open Biol. 2022;12(5): Article 210387.","journal-title":"Open Biol"},{"issue":"7","key":"e_1_3_2_149_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.xgen.2025.100888","article-title":"Single-cell profiling of bone metastasis ecosystems from multiple cancer types reveals convergent and divergent mechanisms of bone colonization","volume":"5","author":"Liu F","year":"2025","unstructured":"Liu F, Ding Y, Xu Z, Hao X, Pan T, Miles G, Wang S, Wu YH, Liu J, Bado IL, et al. Single-cell profiling of bone metastasis ecosystems from multiple cancer types reveals convergent and divergent mechanisms of bone colonization. Cell Genom. 2025;5(7): Article 100888.","journal-title":"Cell Genom"},{"key":"e_1_3_2_150_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.04.013"},{"issue":"2","key":"e_1_3_2_151_2","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae1298","article-title":"Mapping the spatial atlas of the human bone tissue integrating spatial and single-cell transcriptomics","volume":"53","author":"Lin W","year":"2025","unstructured":"Lin W, Li Y, Qiu C, Zou B, Gong Y, Zhang X, Tian D, Sherman W, Sanchez F, Wu D, et al. Mapping the spatial atlas of the human bone tissue integrating spatial and single-cell transcriptomics. Nucleic Acids Res. 2025;53(2): Article gkae1298.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"e_1_3_2_152_2","doi-asserted-by":"crossref","first-page":"29493","DOI":"10.1038\/s41598-024-80993-z","article-title":"Single-cell RNA sequencing reveals multiple immune cell subpopulations promote the formation of abnormal bone microenvironment in osteoporosis","volume":"14","author":"Yang W","year":"2024","unstructured":"Yang W, Wang Y, Mo K, Chen W, Xie X. Single-cell RNA sequencing reveals multiple immune cell subpopulations promote the formation of abnormal bone microenvironment in osteoporosis. Sci Rep. 2024;14(1):29493.","journal-title":"Sci Rep"},{"issue":"1","key":"e_1_3_2_153_2","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/s42003-025-08316-0","article-title":"Integrating spatial and single-cell transcriptomics to characterize mouse long bone fracture healing process","volume":"8","author":"Wang H","year":"2025","unstructured":"Wang H, He X, Ma M, Dou T, Wei Y, Rux D, Qin L, Yang Y, Zhu Y, Yao L. Integrating spatial and single-cell transcriptomics to characterize mouse long bone fracture healing process. Commun Biol. 2025;8(1):887.","journal-title":"Commun Biol"},{"key":"e_1_3_2_154_2","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-00318-y"},{"issue":"1","key":"e_1_3_2_155_2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s12672-025-02353-1","article-title":"Single-cell RNA sequencing reveals key signaling pathways and biological functions in giant cell tumors of bone","volume":"16","author":"Lin Z","year":"2025","unstructured":"Lin Z, Chen Z. Single-cell RNA sequencing reveals key signaling pathways and biological functions in giant cell tumors of bone. Discov Oncol. 2025;16(1):573.","journal-title":"Discov Oncol"},{"issue":"1","key":"e_1_3_2_156_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41572-022-00409-y","article-title":"Osteosarcoma","volume":"8","author":"Beird HC","year":"2022","unstructured":"Beird HC, Bielack SS, Flanagan AM, Gill J, Heymann D, Janeway KA, Livingston JA, Roberts RD, Strauss SJ, Gorlick R. Osteosarcoma. Nat Rev Dis Primers. 2022;8(1):77.","journal-title":"Nat Rev Dis Primers"},{"issue":"16","key":"e_1_3_2_157_2","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1177\/1535370220949139","article-title":"Alternative splicing of leptin receptor overlapping transcript in osteosarcoma","volume":"245","author":"Rothzerg E","year":"2020","unstructured":"Rothzerg E, Ho XD, Xu J, Wood D, M\u00e4rtson A, Maasalu K, Koks S. Alternative splicing of leptin receptor overlapping transcript in osteosarcoma. Exp Biol Med. 2020;245(16):1437\u20131443.","journal-title":"Exp Biol Med"},{"issue":"24","key":"e_1_3_2_158_2","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.185269","article-title":"SNRNP70 regulates the splicing of CD55 to promote osteosarcoma progression","volume":"9","author":"Li W","year":"2024","unstructured":"Li W, Wang L, Tian W, Ji W, Bing D, Wang Y, Xu B, Feng J, Zhang P, Liang H, et al. SNRNP70 regulates the splicing of CD55 to promote osteosarcoma progression. JCI Insight. 2024;9(24): Article e185269.","journal-title":"JCI Insight"},{"key":"e_1_3_2_159_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2632"},{"issue":"1","key":"e_1_3_2_160_2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1186\/s12885-024-12346-y","article-title":"High expression of SRSF1 facilitates osteosarcoma progression and unveils its potential mechanisms","volume":"24","author":"Li S","year":"2024","unstructured":"Li S, Huang X, Zheng S, Zhang W, Liu F, Cao Q. High expression of SRSF1 facilitates osteosarcoma progression and unveils its potential mechanisms. BMC Cancer. 2024;24(1):580.","journal-title":"BMC Cancer"},{"key":"e_1_3_2_161_2","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201202218"},{"key":"e_1_3_2_162_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1500"},{"key":"e_1_3_2_163_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041264"},{"issue":"7","key":"e_1_3_2_164_2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/s41388-018-0486-7","article-title":"VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a \u03b21 integrin\/VEGFR autocrine loop","volume":"38","author":"Boudria A","year":"2019","unstructured":"Boudria A, Abou Faycal C, Jia T, Gout S, Keramidas M, Didier C, Lemaitre N, Manet S, Coll J-L, Toffart A-C, et al. VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a \u03b21 integrin\/VEGFR autocrine loop. Oncogene. 2019;38(7):1050\u20131066.","journal-title":"Oncogene"},{"issue":"14","key":"e_1_3_2_165_2","first-page":"4123","article-title":"VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma","volume":"62","author":"Bates DO","year":"2002","unstructured":"Bates DO, Cui TG, Doughty JM, Winkler M, Sugiono M, Shields JD, Peat D, Gillatt D, Harper SJ. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res. 2002;62(14):4123\u20134131.","journal-title":"Cancer Res"},{"issue":"8","key":"e_1_3_2_166_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18706","article-title":"The splicing factor YBX1 promotes the progression of osteosarcoma by upregulating VEGF165 and downregulating VEGF165b","volume":"9","author":"Quan B","year":"2023","unstructured":"Quan B, Li Z, Yang H, Li S, Yan X, Wang Y. The splicing factor YBX1 promotes the progression of osteosarcoma by upregulating VEGF165 and downregulating VEGF165b. Heliyon. 2023;9(8): Article e18706.","journal-title":"Heliyon"},{"issue":"26","key":"e_1_3_2_167_2","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/s41388-025-03375-3","article-title":"KPNA2 promotes osteosarcoma progression by regulating the alternative splicing of DDX3X mediated by YBX1","volume":"44","author":"Cao L","year":"2025","unstructured":"Cao L, Jia K, Van Tine BA, Yu Y, Peng Y, Chen X, Pan Q, Yang W, Zhang Z, Shao Z, et al. KPNA2 promotes osteosarcoma progression by regulating the alternative splicing of DDX3X mediated by YBX1. Oncogene. 2025;44(26):2186\u20132200.","journal-title":"Oncogene"},{"issue":"1","key":"e_1_3_2_168_2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41420-023-01435-9","article-title":"Novel insights into the METTL3-METTL14 complex in musculoskeletal diseases","volume":"9","author":"Xu Y","year":"2023","unstructured":"Xu Y, Zhang Y, Luo Y, Qiu G, Lu J, He M, Wang Y. Novel insights into the METTL3-METTL14 complex in musculoskeletal diseases. Cell Death Discov. 2023;9(1):170.","journal-title":"Cell Death Discov"},{"issue":"4","key":"e_1_3_2_169_2","first-page":"1443","article-title":"METTL3 regulates alternative splicing of cell cycle-related genes via crosstalk between mRNA m6a modifications and splicing factors","volume":"13","author":"Kim Y","year":"2023","unstructured":"Kim Y, Shin S, Kwon S, Moon K, Baek SV, Jo A, Kim HS, Hwang GH, Bae S, Kim YH, et al. METTL3 regulates alternative splicing of cell cycle-related genes via crosstalk between mRNA m6a modifications and splicing factors. Am J Cancer Res. 2023;13(4):1443\u20131456.","journal-title":"Am J Cancer Res"},{"issue":"10","key":"e_1_3_2_170_2","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1460","article-title":"Crosstalk between m6A modification and alternative splicing during cancer progression","volume":"13","author":"Zhu ZM","year":"2023","unstructured":"Zhu ZM, Huo FC, Zhang J, Shan HJ, Pei DS. Crosstalk between m6A modification and alternative splicing during cancer progression. Clin Transl Med. 2023;13(10): Article e1460.","journal-title":"Clin Transl Med"},{"key":"e_1_3_2_171_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104142","article-title":"METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma","volume":"82","author":"Li HB","year":"2022","unstructured":"Li HB, Huang G, Tu J, Lv DM, Jin QL, Chen JK, Zou YT, Lee DF, Shen JN, Xie XB. METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma. EBioMedicine. 2022;82: Article 104142.","journal-title":"EBioMedicine"},{"key":"e_1_3_2_172_2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.700963","article-title":"LncRNA KASRT serves as a potential treatment target by regulating SRSF1-related KLF6 alternative splicing and the P21\/CCND1 pathway in osteosarcoma: An in\u00a0vitro and in\u00a0vivo study","volume":"11","author":"Chen K","year":"2021","unstructured":"Chen K, Li C, Huang S, Chen Y, Zhu X. LncRNA KASRT serves as a potential treatment target by regulating SRSF1-related KLF6 alternative splicing and the P21\/CCND1 pathway in osteosarcoma: An in\u00a0vitro and in\u00a0vivo study. Front Oncol. 2021;11: Article 700963.","journal-title":"Front Oncol"},{"key":"e_1_3_2_173_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-011-0049-x"},{"key":"e_1_3_2_174_2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fendo.2013.00006","article-title":"Anabolic effects of IGF-1 signaling on the skeleton","volume":"4","author":"Tahimic CG","year":"2013","unstructured":"Tahimic CG, Wang Y, Bikle DD. Anabolic effects of IGF-1 signaling on the skeleton. Front Endocrinol. 2013;4:6.","journal-title":"Front Endocrinol"},{"issue":"19","key":"e_1_3_2_175_2","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.3390\/ijms21196995","article-title":"Role of alternatively spliced messenger RNA (mRNA) isoforms of the insulin-like growth factor 1 (IGF1) in selected human tumors","volume":"21","author":"Kasprzak A","year":"2020","unstructured":"Kasprzak A, Szaflarski W. Role of alternatively spliced messenger RNA (mRNA) isoforms of the insulin-like growth factor 1 (IGF1) in selected human tumors. Int J Mol Sci. 2020;21(19):6995.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"e_1_3_2_176_2","first-page":"4259","article-title":"IGF1Ec expression in MG-63 human osteoblast-like osteosarcoma cells","volume":"31","author":"Philippou A","year":"2011","unstructured":"Philippou A, Armakolas A, Panteleakou Z, Pissimissis N, Nezos A, Theos A, Kaparelou M, Armakolas N, Pneumaticos SG, Koutsilieris M. IGF1Ec expression in MG-63 human osteoblast-like osteosarcoma cells. Anticancer Res. 2011;31(12):4259\u20134265.","journal-title":"Anticancer Res"},{"issue":"11","key":"e_1_3_2_177_2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026179","article-title":"Somatic TP53 mutations in the era of genome sequencing","volume":"6","author":"Hainaut P","year":"2016","unstructured":"Hainaut P, Pfeifer GP. Somatic TP53 mutations in the era of genome sequencing. Cold Spring Harb Perspect Med. 2016;6(11): Article a026179.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"e_1_3_2_178_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3115"},{"issue":"1","key":"e_1_3_2_179_2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.celrep.2014.03.003","article-title":"Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma","volume":"7","author":"Chen X","year":"2014","unstructured":"Chen X, Bahrami A, Pappo A, Easton J, Dalton J, Hedlund E, Ellison D, Shurtleff S, Wu G, Wei L, et al. Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. Cell Rep. 2014;7(1):104\u2013112.","journal-title":"Cell Rep"},{"issue":"12","key":"e_1_3_2_180_2","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/cdd.2011.120","article-title":"Biological functions of p53 isoforms through evolution: Lessons from animal and cellular models","volume":"18","author":"Marcel V","year":"2011","unstructured":"Marcel V, Dichtel-Danjoy ML, Sagne C, Hafsi H, Ma D, Ortiz-Cuaran S, Olivier M, Hall J, Mollereau B, Hainaut P, et al. Biological functions of p53 isoforms through evolution: Lessons from animal and cellular models. Cell Death Differ. 2011;18(12):1815\u20131824.","journal-title":"Cell Death Differ"},{"key":"e_1_3_2_181_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-0145"},{"key":"e_1_3_2_182_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-2637"},{"key":"e_1_3_2_183_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M605405200"},{"key":"e_1_3_2_184_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-0215"},{"issue":"3","key":"e_1_3_2_185_2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ijc.21206","article-title":"Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis","volume":"117","author":"Bartel F","year":"2005","unstructured":"Bartel F, Schulz J, B\u00f6hnke A, Bl\u00fcmke K, Kappler M, Bache M, Schmidt H, Wurl P, Taubert H, Hauptmann S. Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis. Int J Cancer. 2005;117(3):469\u2013475.","journal-title":"Int J Cancer"},{"key":"e_1_3_2_186_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2021.100403","article-title":"Interleukin-24 inhibits the phenotype and tumorigenicity of cancer stem cell in osteosarcoma via downregulation Notch and Wnt\/\u03b2-catenin signaling","volume":"31","author":"Zhuo B","year":"2021","unstructured":"Zhuo B, Wang X, Shen Y, Li J, Li S, Li Y, Wang R. Interleukin-24 inhibits the phenotype and tumorigenicity of cancer stem cell in osteosarcoma via downregulation Notch and Wnt\/\u03b2-catenin signaling. J Bone Oncol. 2021;31: Article 100403.","journal-title":"J Bone Oncol"},{"issue":"1","key":"e_1_3_2_187_2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41392-020-00380-8","article-title":"IL-24 armored CAR19-T cells show enhanced antitumor activity and persistence","volume":"6","author":"Hu Q","year":"2021","unstructured":"Hu Q, Zhang Y, Wang P, Zhou M, Hu Z, Liu C, Liu M, Wu L, Liu X, Liang D. IL-24 armored CAR19-T cells show enhanced antitumor activity and persistence. Signal Transduct Target Ther. 2021;6(1):14.","journal-title":"Signal Transduct Target Ther"},{"key":"e_1_3_2_188_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2011.07.020"},{"key":"e_1_3_2_189_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108765","article-title":"Signaling pathways and targeted therapies in Ewing sarcoma","volume":"266","author":"Jia K","year":"2025","unstructured":"Jia K, Cao L, Yu Y, Jing D, Wu W, Van Tine BA, Shao Z. Signaling pathways and targeted therapies in Ewing sarcoma. Pharmacol Ther. 2025;266: Article 108765.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"e_1_3_2_190_2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s13402-013-0126-8","article-title":"Multiple splice variants of EWSR1-ETS fusion transcripts co-existing in the Ewing sarcoma family of tumors","volume":"36","author":"Pat\u00f3cs B","year":"2013","unstructured":"Pat\u00f3cs B, N\u00e9meth K, Garami M, Arat\u00f3 G, Kovalszky I, Szendr\u0151i M, Fekete G. Multiple splice variants of EWSR1-ETS fusion transcripts co-existing in the Ewing sarcoma family of tumors. Cellular Oncology (Dordrecht, Netherlands). 2013;36(3):191\u2013200.","journal-title":"Cellular Oncology (Dordrecht, Netherlands)"},{"issue":"11","key":"e_1_3_2_191_2","doi-asserted-by":"crossref","first-page":"E1307","DOI":"10.1073\/pnas.1500536112","article-title":"Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing","volume":"112","author":"Selvanathan SP","year":"2015","unstructured":"Selvanathan SP, Graham GT, Erkizan HV, Dirksen U, Natarajan TG, Dakic A, Yu S, Liu X, Paulsen MT, Ljungman ME, et al. Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing. Proc Natl Acad Sci USA. 2015;112(11):E1307\u2013E1316.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"e_1_3_2_192_2","first-page":"9619","article-title":"EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex","volume":"47","author":"Selvanathan SP","year":"2019","unstructured":"Selvanathan SP, Graham GT, Grego AR, Baker TM, Hogg JR, Simpson M, Batish M, Crompton B, Stegmaier K, Tomazou EM, et al. EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex. Nucleic Acids Res. 2019;47(18):9619\u20139636.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"e_1_3_2_193_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13072-019-0264-y","article-title":"The BAF complex in development and disease","volume":"12","author":"Alfert A","year":"2019","unstructured":"Alfert A, Moreno N, Kerl K. The BAF complex in development and disease. Epigenetics Chromatin. 2019;12(1):19.","journal-title":"Epigenetics Chromatin"},{"key":"e_1_3_2_194_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.03.077"},{"key":"e_1_3_2_195_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-022-02383-x"},{"key":"e_1_3_2_196_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2251"},{"key":"e_1_3_2_197_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2011.05.035"},{"key":"e_1_3_2_198_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2021.100404"},{"key":"e_1_3_2_199_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab305"},{"issue":"499","key":"e_1_3_2_200_2","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aam8429","article-title":"Inhibition of the oncogenic fusion protein EWS-FLI1 causes G(2)-M cell cycle arrest and enhanced vincristine sensitivity in Ewing\u2019s sarcoma","volume":"10","author":"Z\u00f6llner SK","year":"2017","unstructured":"Z\u00f6llner SK, Selvanathan SP, Graham GT, Commins RMT, Hong SH, Moseley E, Parks S, Haladyna JN, Erkizan HV, Dirksen U, et al. Inhibition of the oncogenic fusion protein EWS-FLI1 causes G(2)-M cell cycle arrest and enhanced vincristine sensitivity in Ewing\u2019s sarcoma. Sci Signal. 2017;10(499): Article eaam8429.","journal-title":"Sci Signal"},{"key":"e_1_3_2_201_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020328"},{"issue":"21","key":"e_1_3_2_202_2","doi-asserted-by":"crossref","first-page":"12270","DOI":"10.1093\/nar\/gkx831","article-title":"hnRNPM guides an alternative splicing program in response to inhibition of the PI3K\/AKT\/mTOR pathway in Ewing sarcoma cells","volume":"45","author":"Passacantilli I","year":"2017","unstructured":"Passacantilli I, Frisone P, De Paola E, Fidaleo M, Paronetto MP. hnRNPM guides an alternative splicing program in response to inhibition of the PI3K\/AKT\/mTOR pathway in Ewing sarcoma cells. Nucleic Acids Res. 2017;45(21):12270\u201312284.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_2_203_2","doi-asserted-by":"publisher","DOI":"10.1261\/rna.072454.119"},{"issue":"8","key":"e_1_3_2_204_2","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/cncr.26488","article-title":"CAPER-\u03b1 alternative splicing regulates the expression of vascular endothelial growth factor\u2081\u2086\u2085 in Ewing sarcoma cells","volume":"118","author":"Huang G","year":"2012","unstructured":"Huang G, Zhou Z, Wang H, Kleinerman ES. CAPER-\u03b1 alternative splicing regulates the expression of vascular endothelial growth factor\u2081\u2086\u2085 in Ewing sarcoma cells. Cancer. 2012;118(8):2106\u20132116.","journal-title":"Cancer"},{"issue":"7","key":"e_1_3_2_205_2","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/sj.bjc.6604309","article-title":"The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice","volume":"98","author":"Rennel E","year":"2008","unstructured":"Rennel E, Waine E, Guan H, Sch\u00fcler Y, Leenders W, Woolard J, Sugiono M, Gillatt D, Kleinerman E, Bates D, et al. The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice. Br J Cancer. 2008;98(7):1250\u20131257.","journal-title":"Br J Cancer"},{"key":"e_1_3_2_206_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.08.113"},{"issue":"3","key":"e_1_3_2_207_2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1158\/1541-7786.MCR-11-0390","article-title":"A functional, new short isoform of death receptor 4 in Ewing\u2019s sarcoma cell lines may be involved in TRAIL sensitivity\/resistance mechanisms","volume":"10","author":"Picarda G","year":"2012","unstructured":"Picarda G, Surget S, Guiho R, T\u00e9letch\u00e9a S, Berreur M, Tirode F, et al. A functional, new short isoform of death receptor 4 in Ewing\u2019s sarcoma cell lines may be involved in TRAIL sensitivity\/resistance mechanisms. Mol Cancer Res. 2012;10(3):336\u2013346.","journal-title":"Mol Cancer Res"},{"issue":"11","key":"e_1_3_2_208_2","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.3390\/cimb46110751","article-title":"Genetics and molecular pathogenesis of the chondrosarcoma: A review of the literature","volume":"46","author":"Iacobescu GL","year":"2024","unstructured":"Iacobescu GL, Corlatescu AD, Serban B, Spiridonica R, Costin HP, Cirstoiu C. Genetics and molecular pathogenesis of the chondrosarcoma: A review of the literature. Curr Issues Mol Biol. 2024;46(11):12658\u201312671.","journal-title":"Curr Issues Mol Biol"},{"key":"e_1_3_2_209_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.06.052"},{"key":"e_1_3_2_210_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2020.08.031"},{"issue":"1","key":"e_1_3_2_211_2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s12967-024-05364-8","article-title":"An overview of CCN4 (WISP1) role in human diseases","volume":"22","author":"Singh K","year":"2024","unstructured":"Singh K, Oladipupo SS. An overview of CCN4 (WISP1) role in human diseases. J Transl Med. 2024;22(1):601.","journal-title":"J Transl Med"},{"issue":"4","key":"e_1_3_2_212_2","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3892\/ijo.25.4.1201","article-title":"Characterization of human ARHGAP10 gene in silico","volume":"25","author":"Katoh M","year":"2004","unstructured":"Katoh M, Katoh M. Characterization of human ARHGAP10 gene in silico. Int J Oncol. 2004;25(4):1201\u20131206.","journal-title":"Int J Oncol"},{"issue":"1","key":"e_1_3_2_213_2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12935-021-02022-7","article-title":"ARHGAP10 inhibits the epithelial-mesenchymal transition of non-small cell lung cancer by inactivating PI3K\/Akt\/GSK3\u03b2 signaling pathway","volume":"21","author":"Lin LL","year":"2021","unstructured":"Lin LL, Yang F, Zhang DH, Hu C, Yang S, Chen XQ. ARHGAP10 inhibits the epithelial-mesenchymal transition of non-small cell lung cancer by inactivating PI3K\/Akt\/GSK3\u03b2 signaling pathway. Cancer Cell Int. 2021;21(1):320.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"e_1_3_2_214_2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13046-021-01908-8","article-title":"Fibronectin as a multiregulatory molecule crucial in tumor matrisome: From structural and functional features to clinical practice in oncology","volume":"40","author":"Spada S","year":"2021","unstructured":"Spada S, Tocci A, Di Modugno F, Nistic\u00f2 P. Fibronectin as a multiregulatory molecule crucial in tumor matrisome: From structural and functional features to clinical practice in oncology. J Exp Clin Cancer Res. 2021;40(1):102.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"e_1_3_2_215_2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/jcb.10687","article-title":"Alternative splicing of fibronectin mRNAs in chondrosarcoma cells: Role of far upstream intron sequences","volume":"90","author":"Flanagan M","year":"2003","unstructured":"Flanagan M, Liang H, Norton PA. Alternative splicing of fibronectin mRNAs in chondrosarcoma cells: Role of far upstream intron sequences. J Cell Biochem. 2003;90(4):709\u2013718.","journal-title":"J Cell Biochem"},{"issue":"1","key":"e_1_3_2_216_2","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/ATVBAHA.120.314013","article-title":"Alternative splicing of FN (fibronectin) regulates the composition of the arterial wall under low flow","volume":"41","author":"Murphy PA","year":"2021","unstructured":"Murphy PA, Jailkhani N, Nicholas SA, Del Rosario AM, Balsbaugh JL, Begum S, Kimble A, Hynes RO. Alternative splicing of FN (fibronectin) regulates the composition of the arterial wall under low flow. Arterioscler Thromb Vasc Biol. 2021;41(1):e18\u2013e32.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"e_1_3_2_217_2","doi-asserted-by":"crossref","first-page":"19835","DOI":"10.1038\/s41598-021-99079-1","article-title":"Identification of splice regulators of fibronectin-EIIIA and EIIIB by direct measurement of exon usage in a flow-cytometry based CRISPR screen","volume":"11","author":"Hensel JA","year":"2021","unstructured":"Hensel JA, Heineman BD, Kimble AL, Jellison ER, Reese B, Murphy PA. Identification of splice regulators of fibronectin-EIIIA and EIIIB by direct measurement of exon usage in a flow-cytometry based CRISPR screen. Sci Rep. 2021;11(1):19835.","journal-title":"Sci Rep"},{"issue":"2","key":"e_1_3_2_218_2","first-page":"1103","article-title":"Alternative splicing of fibronectin transcripts in osteochondrogenic tumors","volume":"21","author":"Matsui Y","year":"2001","unstructured":"Matsui Y, Nakata K, Araki N, Ozono K, Fujita Y, Tsumaki N, et al. Alternative splicing of fibronectin transcripts in osteochondrogenic tumors. Anticancer Res. 2001;21(2A):1103\u20131106.","journal-title":"Anticancer Res"},{"issue":"13","key":"e_1_3_2_219_2","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.3390\/cancers14133263","article-title":"Regulation and function of matrix metalloproteinase-13 in cancer progression and metastasis","volume":"14","author":"Li S","year":"2022","unstructured":"Li S, Pritchard DM, Yu LG. Regulation and function of matrix metalloproteinase-13 in cancer progression and metastasis. Cancer. 2022;14(13):3263.","journal-title":"Cancer"},{"issue":"7","key":"e_1_3_2_220_2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S1063-4584(03)00079-7","article-title":"Identification and differential expression of human collagenase-3 mRNA species derived from internal deletion, alternative splicing, and different polyadenylation and transcription initiation sites","volume":"11","author":"Tardif G","year":"2003","unstructured":"Tardif G, Dupuis M, Reboul P, Geng CS, Pelletier JP, Ranger P, et al. Identification and differential expression of human collagenase-3 mRNA species derived from internal deletion, alternative splicing, and different polyadenylation and transcription initiation sites. Osteoarthr Cartil. 2003;11(7):524\u2013537.","journal-title":"Osteoarthr Cartil"},{"key":"e_1_3_2_221_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cr.7290106"},{"issue":"6","key":"e_1_3_2_222_2","first-page":"4169","article-title":"Differential expression of aggrecan mRNA isoforms by chondrosarcoma cells","volume":"22","author":"Matsui Y","year":"2002","unstructured":"Matsui Y, Araki N, Tsuboi H, Tsumaki N, Nakata K, Kawabata H, Eyre DR, Yoshikawa H. Differential expression of aggrecan mRNA isoforms by chondrosarcoma cells. Anticancer Res. 2002;22(6C):4169\u20134172.","journal-title":"Anticancer Res"},{"issue":"11","key":"e_1_3_2_223_2","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.3390\/biom12111689","article-title":"Tenascin-C: A key regulator in angiogenesis during wound healing","volume":"12","author":"Wang Y","year":"2022","unstructured":"Wang Y, Wang G, Liu H. Tenascin-C: A key regulator in angiogenesis during wound healing. Biomolecules. 2022;12(11):4169\u20134172.","journal-title":"Biomolecules"},{"issue":"4","key":"e_1_3_2_224_2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000055338","article-title":"The clinical significance of tenascin-C splice variant expression in chondrosarcoma","volume":"61","author":"Ghert MA","year":"2001","unstructured":"Ghert MA, Jung ST, Qi W, Harrelson JM, Erickson HP, Block JA, Scully SP. The clinical significance of tenascin-C splice variant expression in chondrosarcoma. Oncology. 2001;61(4):306\u2013314.","journal-title":"Oncology"},{"issue":"3","key":"e_1_3_2_225_2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1247\/csf.26.179","article-title":"Tenascin-C splice variant adhesive\/anti-adhesive effects on chondrosarcoma cell attachment to fibronectin","volume":"26","author":"Ghert MA","year":"2001","unstructured":"Ghert MA, Qi WN, Erickson HP, Block JA, Scully SP. Tenascin-C splice variant adhesive\/anti-adhesive effects on chondrosarcoma cell attachment to fibronectin. Cell Struct Funct. 2001;26(3):179\u2013187.","journal-title":"Cell Struct Funct"},{"issue":"5","key":"e_1_3_2_226_2","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3390\/cancers13050935","article-title":"Collagen type XI alpha 1 (COL11A1): A novel biomarker and a key player in cancer","volume":"13","author":"Nallanthighal S","year":"2021","unstructured":"Nallanthighal S, Heiserman JP, Cheon DJ. Collagen type XI alpha 1 (COL11A1): A novel biomarker and a key player in cancer. Cancer. 2021;13(5):935.","journal-title":"Cancer"},{"issue":"6","key":"e_1_3_2_227_2","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100054RR","article-title":"Collagen XI alpha 1 chain, a potential therapeutic target for cancer","volume":"35","author":"Liu Z","year":"2021","unstructured":"Liu Z, Lai J, Jiang H, Ma C, Huang H. Collagen XI alpha 1 chain, a potential therapeutic target for cancer. FASEB J. 2021;35(6): Article e21603.","journal-title":"FASEB J"},{"issue":"2","key":"e_1_3_2_228_2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3835(97)00468-0","article-title":"Splicing patterns of type XI collagen transcripts act as molecular markers for osteochondrogenic tumors","volume":"124","author":"Matsui Y","year":"1998","unstructured":"Matsui Y, Kimura T, Tsumaki N, Nakata K, Yasui N, Araki N, Hashimoto N, Uchida A, Ochi T. Splicing patterns of type XI collagen transcripts act as molecular markers for osteochondrogenic tumors. Cancer Lett. 1998;124(2):143\u2013148.","journal-title":"Cancer Lett"},{"key":"e_1_3_2_229_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(02)00395-5"},{"key":"e_1_3_2_230_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2015.08.002"},{"issue":"1","key":"e_1_3_2_231_2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41591-022-02128-z","article-title":"Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: A phase 1 trial","volume":"29","author":"Hong DS","year":"2023","unstructured":"Hong DS, Van Tine BA, Biswas S, McAlpine C, Johnson ML, Olszanski AJ, Clarke JM, Araujo D, Blumenschein GR, Kebria P, et al. Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: A phase 1 trial. Nat Med. 2023;29(1):104\u2013114.","journal-title":"Nat Med"},{"issue":"1","key":"e_1_3_2_232_2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1074\/jbc.M109018200","article-title":"The EWS\/NOR1 fusion gene product gains a novel activity affecting pre-mRNA splicing","volume":"277","author":"Ohkura N","year":"2002","unstructured":"Ohkura N, Yaguchi H, Tsukada T, Yamaguchi K. The EWS\/NOR1 fusion gene product gains a novel activity affecting pre-mRNA splicing. J Biol Chem. 2002;277(1):535\u2013543.","journal-title":"J Biol Chem"},{"key":"e_1_3_2_233_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2004.03.040"},{"issue":"1","key":"e_1_3_2_234_2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone metastases","volume":"6","author":"Coleman RE","year":"2020","unstructured":"Coleman RE, Croucher PI, Padhani AR, Cl\u00e9zardin P, Chow E, Fallon M, Guise T, Colangeli S, Capanna R, Costa L. Bone metastases. Nat Rev Dis Primers. 2020;6(1):83.","journal-title":"Nat Rev Dis Primers"},{"issue":"26","key":"e_1_3_2_235_2","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1038\/onc.2010.130","article-title":"Novel alternatively spliced ADAM8 isoforms contribute to the aggressive bone metastatic phenotype of lung cancer","volume":"29","author":"Hern\u00e1ndez I","year":"2010","unstructured":"Hern\u00e1ndez I, Moreno JL, Zandueta C, Montuenga L, Lecanda F. Novel alternatively spliced ADAM8 isoforms contribute to the aggressive bone metastatic phenotype of lung cancer. Oncogene. 2010;29(26):3758\u20133769.","journal-title":"Oncogene"},{"key":"e_1_3_2_236_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-023-00667-1"},{"key":"e_1_3_2_237_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315815"},{"issue":"11","key":"e_1_3_2_238_2","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.3390\/ijms22115515","article-title":"AR-V7 in metastatic prostate cancer: A strategy beyond redemption","volume":"22","author":"Sobhani N","year":"2021","unstructured":"Sobhani N, Neeli PK, D\u2019Angelo A, Pittacolo M, Sirico M, Galli IC, Roviello G, Nesi G. AR-V7 in metastatic prostate cancer: A strategy beyond redemption. Int J Mol Sci. 2021;22(11):5515.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_2_239_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2017-00109"},{"issue":"11","key":"e_1_3_2_240_2","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168649","article-title":"Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs","volume":"134","author":"Han D","year":"2024","unstructured":"Han D, Labaf M, Zhao Y, Owiredu J, Zhang S, Patel K, Venkataramani K, Steinfeld JS, Han W, Li M, et al. Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs. J Clin Invest. 2024;134(11): Article e168649.","journal-title":"J Clin Invest"},{"issue":"11","key":"e_1_3_2_241_2","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3390\/vaccines12111273","article-title":"Vaccination against androgen receptor splice variants to immunologically target prostate cancer","volume":"12","author":"Marek RD","year":"2024","unstructured":"Marek RD, Halabi S, Wang ME, McBane J, Wei J, Wang T, Yang X, Liu C, Lei G, Lyerly HK, et al. Vaccination against androgen receptor splice variants to immunologically target prostate cancer. Vaccine. 2024;12(11):1273.","journal-title":"Vaccine"},{"issue":"8","key":"e_1_3_2_242_2","first-page":"2215","article-title":"Beyond prostate cancer: An androgen receptor splice variant expression in multiple malignancies, non-cancer pathologies, and development","volume":"11","author":"Katleba KD","year":"2023","unstructured":"Katleba KD, Ghosh PM, Mudryj M. Beyond prostate cancer: An androgen receptor splice variant expression in multiple malignancies, non-cancer pathologies, and development. Biomedicine. 2023;11(8):2215.","journal-title":"Biomedicine"},{"issue":"11","key":"e_1_3_2_243_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027970","article-title":"Androgen receptor variants occur frequently in castration resistant prostate cancer metastases","volume":"6","author":"Zhang X","year":"2011","unstructured":"Zhang X, Morrissey C, Sun S, Ketchandji M, Nelson PS, True LD, Vakar-Lopez F, Vessella RL, Plymate SR. Androgen receptor variants occur frequently in castration resistant prostate cancer metastases. PLOS ONE. 2011;6(11): Article e27970.","journal-title":"PLOS ONE"},{"issue":"4","key":"e_1_3_2_244_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019059","article-title":"Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival","volume":"6","author":"H\u00f6rnberg E","year":"2011","unstructured":"H\u00f6rnberg E, Ylitalo EB, Crnalic S, Antti H, Stattin P, Widmark A, Bergh A, Wikstrom P. Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival. PLOS ONE. 2011;6(4): Article e19059.","journal-title":"PLOS ONE"},{"issue":"14","key":"e_1_3_2_245_2","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1158\/0008-5472.CAN-07-1330","article-title":"A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells","volume":"67","author":"Chen N","year":"2007","unstructured":"Chen N, Ye XC, Chu K, Navone NM, Sage EH, Yu-Lee LY, Logothetis CJ, Lin SH. A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells. Cancer Res. 2007;67(14):6544\u20136548.","journal-title":"Cancer Res"},{"issue":"39","key":"e_1_3_2_246_2","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1038\/onc.2008.156","article-title":"A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation","volume":"27","author":"Lin SH","year":"2008","unstructured":"Lin SH, Cheng CJ, Lee YC, Ye X, Tsai WW, Kim J, Pasqualini R, Arap W, Navone NM, Tu S-M, et al. A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation. Oncogene. 2008;27(39):5195\u20135203.","journal-title":"Oncogene"},{"issue":"1","key":"e_1_3_2_247_2","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1186\/s12967-025-06865-w","article-title":"The CTSZ-TRA2A-IL32 axis defines a targetable macrophage-dependent pathway in metastatic prostate cancer","volume":"23","author":"Chen S","year":"2025","unstructured":"Chen S, Deng B, Liu Y, Xie L, Xu J, Hu R, Zhao F, Song G, Ni R, Liu H, et al. The CTSZ-TRA2A-IL32 axis defines a targetable macrophage-dependent pathway in metastatic prostate cancer. J Transl Med. 2025;23(1):865.","journal-title":"J Transl Med"},{"issue":"2","key":"e_1_3_2_248_2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41419-023-05627-0","article-title":"RBM3 suppresses stemness remodeling of prostate cancer in bone microenvironment by modulating N6-methyladenosine on CTNNB1 mRNA","volume":"14","author":"Zhang S","year":"2023","unstructured":"Zhang S, Lv C, Niu Y, Li C, Li X, Shang Y, Zhang Y, Zhang Y, Zhang Y, Zeng Y, et al. RBM3 suppresses stemness remodeling of prostate cancer in bone microenvironment by modulating N6-methyladenosine on CTNNB1 mRNA. Cell Death Dis. 2023;14(2):91.","journal-title":"Cell Death Dis"},{"issue":"1","key":"e_1_3_2_249_2","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1038\/s41598-017-05247-7","article-title":"CD44v8-10 as a potential theranostic biomarker for targeting disseminated cancer cells in advanced gastric cancer","volume":"7","author":"Choi ES","year":"2017","unstructured":"Choi ES, Kim H, Kim HP, Choi Y, Goh SH. CD44v8-10 as a potential theranostic biomarker for targeting disseminated cancer cells in advanced gastric cancer. Sci Rep. 2017;7(1):4930.","journal-title":"Sci Rep"},{"key":"e_1_3_2_250_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-1343"},{"key":"e_1_3_2_251_2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1186\/s12885-015-1924-3","article-title":"Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44\u03bd is an indicator for recurrence in advanced cancer","volume":"15","author":"Wu CL","year":"2015","unstructured":"Wu CL, Chao YJ, Yang TM, Chen YL, Chang KC, Hsu HP, Shan YS, Lai MD. Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44\u03bd is an indicator for recurrence in advanced cancer. BMC Cancer. 2015;15:903.","journal-title":"BMC Cancer"},{"key":"e_1_3_2_252_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-023-10367-z"},{"key":"e_1_3_2_253_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.312058.118"},{"issue":"2","key":"e_1_3_2_254_2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ijc.11402","article-title":"Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients","volume":"107","author":"Schmittgen TD","year":"2003","unstructured":"Schmittgen TD, Teske S, Vessella RL, True LD, Zakrajsek BA. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients. Int J Cancer. 2003;107(2):323\u2013329.","journal-title":"Int J Cancer"},{"key":"e_1_3_2_255_2","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1964252"},{"key":"e_1_3_2_256_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3977"},{"key":"e_1_3_2_257_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.04.030"},{"issue":"1","key":"e_1_3_2_258_2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbcan.2017.02.005","article-title":"Osteopontin splice variants and polymorphisms in cancer progression and prognosis","volume":"1868","author":"Briones-Orta MA","year":"2017","unstructured":"Briones-Orta MA, Avenda\u00f1o-V\u00e1zquez SE, Aparicio-Bautista DI, Coombes JD, Weber GF, Syn WK. Osteopontin splice variants and polymorphisms in cancer progression and prognosis. Biochim Biophys Acta Rev Cancer. 2017;1868(1):93\u2013108.A.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"5","key":"e_1_3_2_259_2","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.21873\/anticanres.11561","article-title":"OPN-a splicing variant expression in non-small cell lung cancer and its effects on the bone metastatic abilities of lung cancer cells in\u00a0vitro","volume":"37","author":"Hao C","year":"2017","unstructured":"Hao C, Cui Y, Hu MU, Zhi X, Zhang L, Li W, Wu W, Cheng S, Jiang WG. OPN-a splicing variant expression in non-small cell lung cancer and its effects on the bone metastatic abilities of lung cancer cells in\u00a0vitro. Anticancer Res. 2017;37(5):2245\u20132254.","journal-title":"Anticancer Res"},{"issue":"10","key":"e_1_3_2_260_2","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.3390\/cancers15102670","article-title":"Re-evaluating the role of PTHrP in breast cancer","volume":"15","author":"Kane JF","year":"2023","unstructured":"Kane JF, Johnson RW. Re-evaluating the role of PTHrP in breast cancer. Cancer. 2023;15(10):2670.","journal-title":"Cancer"},{"issue":"11","key":"e_1_3_2_261_2","first-page":"1075","article-title":"PTHrP and breast cancer","volume":"88","author":"Devys A","year":"2001","unstructured":"Devys A, Lortholary A, Audran M. PTHrP and breast cancer. Bull Cancer. 2001;88(11):1075\u20131080.","journal-title":"Bull Cancer"},{"issue":"6","key":"e_1_3_2_262_2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.drup.2008.08.005","article-title":"SPARC in cancer biology: Its role in cancer progression and potential for therapy","volume":"11","author":"Tai IT","year":"2008","unstructured":"Tai IT, Tang MJ. SPARC in cancer biology: Its role in cancer progression and potential for therapy. Drug Resist Updat. 2008;11(6):231\u2013246.","journal-title":"Drug Resist Updat"},{"issue":"5","key":"e_1_3_2_263_2","first-page":"5876","article-title":"SPARC inhibits breast cancer bone metastasis and may be a clinical therapeutic target","volume":"14","author":"Ma J","year":"2017","unstructured":"Ma J, Gao S, Xie X, Sun E, Zhang M, Zhou Q, Lu C. SPARC inhibits breast cancer bone metastasis and may be a clinical therapeutic target. Oncol Lett. 2017;14(5):5876\u20135882.","journal-title":"Oncol Lett"},{"key":"e_1_3_2_264_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030202"},{"issue":"39","key":"e_1_3_2_265_2","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.2174\/1381612820666140619123255","article-title":"SPARC in tumor pathophysiology and as a potential therapeutic target","volume":"20","author":"Feng J","year":"2014","unstructured":"Feng J, Tang L. SPARC in tumor pathophysiology and as a potential therapeutic target. Curr Pharm Des. 2014;20(39):6182\u20136190.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"e_1_3_2_266_2","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.18632\/aging.202231","article-title":"SPOCK1\/SIX1axis promotes breast cancer progression by activating AKT\/mTOR signaling","volume":"13","author":"Xu M","year":"2020","unstructured":"Xu M, Zhang X, Zhang S, Piao J, Yang Y, Wang X, Lin Z. SPOCK1\/SIX1axis promotes breast cancer progression by activating AKT\/mTOR signaling. Aging. 2020;13(1):1032\u20131050.","journal-title":"Aging"},{"key":"e_1_3_2_267_2","doi-asserted-by":"publisher","DOI":"10.3390\/biom11111643"},{"key":"e_1_3_2_268_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2013.02.048"},{"key":"e_1_3_2_269_2","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-10-0568"},{"issue":"4","key":"e_1_3_2_270_2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/emboj.2010.351","article-title":"TGF-\u03b2 regulates isoform switching of FGF receptors and epithelial-mesenchymal transition","volume":"30","author":"Shirakihara T","year":"2011","unstructured":"Shirakihara T, Horiguchi K, Miyazawa K, Ehata S, Shibata T, Morita I, Miyazono K, Saitoh M. TGF-\u03b2 regulates isoform switching of FGF receptors and epithelial-mesenchymal transition. EMBO J. 2011;30(4):783\u2013795.","journal-title":"EMBO J"},{"issue":"15","key":"e_1_3_2_271_2","doi-asserted-by":"crossref","first-page":"8123","DOI":"10.3390\/ijms25158123","article-title":"Get spliced: Uniting alternative splicing and arthritis","volume":"25","author":"Haaren MJH","year":"2024","unstructured":"van Haaren MJH, Steller LB, Vastert SJ, Calis JJA, van Loosdregt J. Get spliced: Uniting alternative splicing and arthritis. Int J Mol Sci. 2024;25(15):8123.","journal-title":"Int J Mol Sci"},{"issue":"17","key":"e_1_3_2_272_2","doi-asserted-by":"crossref","first-page":"e2416536","DOI":"10.1002\/advs.202416536","article-title":"Identification of NIBAN2-regulated RUNX2 alternative splicing presents novel strategies for antagonizing osteoporosis","volume":"12","author":"Zhang S","year":"2025","unstructured":"Zhang S, Yang Z, Xie Y, Zhang Y, Chen Z, Lv X, Deng Z, Huang Z, Cai L, Wei R. Identification of NIBAN2-regulated RUNX2 alternative splicing presents novel strategies for antagonizing osteoporosis. Adv Sci. 2025;12(17):e2416536.","journal-title":"Adv Sci"},{"issue":"9","key":"e_1_3_2_273_2","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022111762","article-title":"Splicing factor YBX1 regulates bone marrow stromal cell fate during aging","volume":"42","author":"Xiao Y","year":"2023","unstructured":"Xiao Y, Cai GP, Feng X, Li YJ, Guo WH, Guo Q, Huang Y, Su T, Li C-J, Luo X-H, et al. Splicing factor YBX1 regulates bone marrow stromal cell fate during aging. EMBO J. 2023;42(9): Article e111762.","journal-title":"EMBO J"},{"issue":"1","key":"e_1_3_2_274_2","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s42003-025-07989-x","article-title":"Glucocorticoids regulate the expression of Srsf1 through Hdac4\/Foxc1 axis to induce apoptosis of osteoblasts","volume":"8","author":"Luo H","year":"2025","unstructured":"Luo H, Wang T, Xie Z, Li F, Yang C, Dong W, Wu J, Wang Q, Xu F, Liu J, et al. Glucocorticoids regulate the expression of Srsf1 through Hdac4\/Foxc1 axis to induce apoptosis of osteoblasts. Commun Biol. 2025;8(1):566.","journal-title":"Commun Biol"},{"issue":"12","key":"e_1_3_2_275_2","doi-asserted-by":"crossref","first-page":"e4742","DOI":"10.1210\/clinem\/dgaa572","article-title":"Gene expression and RNA splicing imputation identifies novel candidate genes associated with osteoporosis","volume":"105","author":"Liu Y","year":"2020","unstructured":"Liu Y, Shen H, Greenbaum J, Liu A, Su KJ, Zhang LS, Zhang L, Tian Q, Hu H-G, He J-S, et al. Gene expression and RNA splicing imputation identifies novel candidate genes associated with osteoporosis. J Clin Endocrinol Metab. 2020;105(12):e4742\u2013e4757.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"e_1_3_2_276_2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12864-024-10181-w","article-title":"RNA-binding proteins potentially regulate the alternative splicing of apoptotic genes during knee osteoarthritis progression","volume":"25","author":"Zhang Z","year":"2024","unstructured":"Zhang Z, Dong L, Tao H, Dong Y, Xiang W, Tao F, Zhao Y. RNA-binding proteins potentially regulate the alternative splicing of apoptotic genes during knee osteoarthritis progression. BMC Genomics. 2024;25(1):293.","journal-title":"BMC Genomics"},{"key":"e_1_3_2_277_2","doi-asserted-by":"publisher","DOI":"10.1177\/19476035231154511"},{"issue":"12","key":"e_1_3_2_278_2","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1093\/hmg\/ddac017","article-title":"A molecular map of long non-coding RNA expression, isoform switching and alternative splicing in osteoarthritis","volume":"31","author":"Katsoula G","year":"2022","unstructured":"Katsoula G, Steinberg J, Tuerlings M, Coutinho de Almeida R, Southam L, Swift D, Meulenbelt I, Wilkinson JM, Zeggini E. A molecular map of long non-coding RNA expression, isoform switching and alternative splicing in osteoarthritis. Hum Mol Genet. 2022;31(12):2090\u20132105.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"e_1_3_2_279_2","doi-asserted-by":"crossref","first-page":"7932","DOI":"10.1038\/s41467-025-63299-0","article-title":"Response splicing quantitative trait loci in primary human chondrocytes identify putative osteoarthritis risk genes","volume":"16","author":"Byun S","year":"2025","unstructured":"Byun S, Shine J, Coryell P, Kramer NE, D\u2019Costa S, Thulson E, Parkus SM, Chubinskaya S, Loeser RF, Diekman BO, et al. Response splicing quantitative trait loci in primary human chondrocytes identify putative osteoarthritis risk genes. Nat Commun. 2025;16(1):7932.","journal-title":"Nat Commun"},{"issue":"1","key":"e_1_3_2_280_2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s42003-024-05889-0","article-title":"Transcript-dependent effects of the CALCA gene on the progression of post-traumatic osteoarthritis in mice","volume":"7","author":"Jiang S","year":"2024","unstructured":"Jiang S, Xie W, Knapstein PR, Donat A, Albertsen LC, Sevecke J, Erdmann C, Appelt J, Fuchs M, Hildebrant A, et al. Transcript-dependent effects of the CALCA gene on the progression of post-traumatic osteoarthritis in mice. Commun Biol. 2024;7(1):223.","journal-title":"Commun Biol"},{"key":"e_1_3_2_281_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00728-X"},{"key":"e_1_3_2_282_2","doi-asserted-by":"crossref","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","article-title":"Osteogenesis imperfecta","volume":"3","author":"Marini JC","year":"2017","unstructured":"Marini JC, Forlino A, B\u00e4chinger HP, Bishop NJ, Byers PH, Paepe A, Fassier F, Fratzl-Zelman N, Kozloff KM, Krakow D, et al. Osteogenesis imperfecta. Nat Rev Dis Primers. 2017;3:17052.","journal-title":"Nat Rev Dis Primers"},{"key":"e_1_3_2_283_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.45.28617"},{"key":"e_1_3_2_284_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144565","article-title":"Rare splicing mutation in COL1A1 gene identified by whole exomes sequencing in a patient with osteogenesis imperfecta type I followed by prenatal diagnosis: A case report and review of the literature","volume":"741","author":"Gug C","year":"2020","unstructured":"Gug C, Caba L, Mozos I, Stoian D, Atasie D, Gug M, Glorduza EV. Rare splicing mutation in COL1A1 gene identified by whole exomes sequencing in a patient with osteogenesis imperfecta type I followed by prenatal diagnosis: A case report and review of the literature. Gene. 2020;741: Article 144565.","journal-title":"Gene"},{"issue":"2","key":"e_1_3_2_285_2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/jmg.38.2.132","article-title":"Homozygosity for a splice site mutation of the COL1A2 gene yields a non-functional pro\u03b1 2(I) chain and an EDS\/OI clinical phenotype","volume":"38","author":"Nicholls AC","year":"2001","unstructured":"Nicholls AC, Valler D, Wallis S, Pope FM. Homozygosity for a splice site mutation of the COL1A2 gene yields a non-functional pro\u03b1 2(I) chain and an EDS\/OI clinical phenotype. J Med Genet. 2001;38(2):132\u2013136.","journal-title":"J Med Genet"},{"issue":"6","key":"e_1_3_2_286_2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/jhg.2016.11","article-title":"Two novel mutations in TMEM38B result in rare autosomal recessive osteogenesis imperfecta","volume":"61","author":"Lv F","year":"2016","unstructured":"Lv F, Xu XJ, Wang JY, Liu Y, Asan, Wang JW, Song LJ, Song TW, Jiang Y, Wang O, et al. Two novel mutations in TMEM38B result in rare autosomal recessive osteogenesis imperfecta. J Hum Genet. 2016;61(6):539\u2013545.","journal-title":"J Hum Genet"},{"key":"e_1_3_2_287_2","doi-asserted-by":"publisher","DOI":"10.1002\/jor.1100140506"},{"key":"e_1_3_2_288_2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/humu.1380110101","article-title":"Low basal transcripts of the COL2A1 collagen gene from lymphoblasts show alternative splicing of exon 12 in the Kniest form of spondyloepiphyseal dysplasia","volume":"1","author":"Yang W","year":"1998","unstructured":"Yang W, Cole WG. Low basal transcripts of the COL2A1 collagen gene from lymphoblasts show alternative splicing of exon 12 in the Kniest form of spondyloepiphyseal dysplasia. Hum Mutat. 1998;Suppl 1:S1\u2013S2.","journal-title":"Hum Mutat"},{"key":"e_1_3_2_289_2","doi-asserted-by":"publisher","DOI":"10.3390\/genes12091395"},{"key":"e_1_3_2_290_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2024.117013","article-title":"The molecular complexity of COL2A1 splicing variants and their significance in phenotype severity","volume":"181","author":"Viakhireva I","year":"2024","unstructured":"Viakhireva I, Bychkov I, Markova T, Shatokhina O, Karandasheva K, Udalova V, Bekhtereva Y, Ryzhkova O, Skoblov M. The molecular complexity of COL2A1 splicing variants and their significance in phenotype severity. Bone. 2024;181: Article 117013.","journal-title":"Bone"},{"key":"e_1_3_2_291_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.05.017"},{"key":"e_1_3_2_292_2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41439-020-0095-1","article-title":"Phenotypes of a family with XLH with a novel PHEX mutation","volume":"7","author":"Yamamoto A","year":"2020","unstructured":"Yamamoto A, Nakamura T, Ohata Y, Kubota T, Ozono K. Phenotypes of a family with XLH with a novel PHEX mutation. Hum Genome Var. 2020;7:8.","journal-title":"Hum Genome Var"},{"issue":"6","key":"e_1_3_2_293_2","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3892\/ijmm.2016.2796","article-title":"Seven novel and six de novo PHEX gene mutations in patients with hypophosphatemic rickets","volume":"38","author":"Li SS","year":"2016","unstructured":"Li SS, Gu JM, Yu WJ, He JW, Fu WZ, Zhang ZL. Seven novel and six de novo PHEX gene mutations in patients with hypophosphatemic rickets. Int J Mol Med. 2016;38(6):1703\u20131714.","journal-title":"Int J Mol Med"},{"issue":"6","key":"e_1_3_2_294_2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3390\/genes15060679","article-title":"A mild presentation of X-linked hypophosphatemia caused by a non-canonical splice site variant in the PHEX gene","volume":"15","author":"Fraga G","year":"2024","unstructured":"Fraga G, Herreros MA, Pybus M, Aza-Carmona M, Pilco-Teran M, Furlano M, Garcia-Borau MJ, Torra R, Ars E. A mild presentation of X-linked hypophosphatemia caused by a non-canonical splice site variant in the PHEX gene. Genes. 2024;15(6):679.","journal-title":"Genes"},{"issue":"7","key":"e_1_3_2_295_2","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/jbmr.2203","article-title":"As little as needed: The extraordinary case of a mild recessive osteopetrosis owing to a novel splicing hypomorphic mutation in the TCIRG1 gene","volume":"29","author":"Sobacchi C","year":"2014","unstructured":"Sobacchi C, Pangrazio A, Lopez AG, Gomez DP, Caldana ME, Susani L, Vezzoni P, Villa A. As little as needed: The extraordinary case of a mild recessive osteopetrosis owing to a novel splicing hypomorphic mutation in the TCIRG1 gene. J Bone Miner Res. 2014;29(7):1646\u20131650.","journal-title":"J Bone Miner Res"},{"issue":"10","key":"e_1_3_2_296_2","doi-asserted-by":"crossref","first-page":"17180","DOI":"10.1002\/jcb.28979","article-title":"Novel c.G630A TCIRG1 mutation causes aberrant splicing resulting in an unusually mild form of autosomal recessive osteopetrosis","volume":"120","author":"Zirngibl RA","year":"2019","unstructured":"Zirngibl RA, Wang A, Yao Y, Manolson MF, Krueger J, Dupuis L, Mendoza-Londono R, Voronov I. Novel c.G630A TCIRG1 mutation causes aberrant splicing resulting in an unusually mild form of autosomal recessive osteopetrosis. J Cell Biochem. 2019;120(10):17180\u201317193.","journal-title":"J Cell Biochem"},{"key":"e_1_3_2_297_2","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2008.234"},{"key":"e_1_3_2_298_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2025.102014","article-title":"A comprehensive report of the clinical and mutational profiles of 30 Iranian malignant infantile osteopetrosis patients","volume":"79","author":"Amirfiroozy A","year":"2025","unstructured":"Amirfiroozy A, Naghinejad M, Rezamand A, Farhangi H, Golchehre Z, Jalali H, Tahari M, Keramatipour M. A comprehensive report of the clinical and mutational profiles of 30 Iranian malignant infantile osteopetrosis patients. Mol Cell Probes. 2025;79: Article 102014.","journal-title":"Mol Cell Probes"},{"issue":"1","key":"e_1_3_2_299_2","doi-asserted-by":"crossref","first-page":"6654","DOI":"10.1038\/s41467-025-60902-2","article-title":"Single cell and spatial alternative splicing analysis with nanopore long read sequencing","volume":"16","author":"Fu Y","year":"2025","unstructured":"Fu Y, Kim H, Roy S, Huang S, Adams JI, Grimes SM, Lau BT, Sathe A, Ji HP, Zhang NR. Single cell and spatial alternative splicing analysis with nanopore long read sequencing. Nat Commun. 2025;16(1):6654.","journal-title":"Nat Commun"},{"issue":"1","key":"e_1_3_2_300_2","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.1038\/s41467-024-51584-3","article-title":"Accurate long-read transcript discovery and quantification at single-cell, pseudo-bulk and bulk resolution with isosceles","volume":"15","author":"Kabza M","year":"2024","unstructured":"Kabza M, Ritter A, Byrne A, Sereti K, Le D, Stephenson W, Sterne-Weiler T. Accurate long-read transcript discovery and quantification at single-cell, pseudo-bulk and bulk resolution with isosceles. Nat Commun. 2024;15(1):7316.","journal-title":"Nat Commun"},{"issue":"2","key":"e_1_3_2_301_2","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btaf028","article-title":"ELLIPSIS: Robust quantification of splicing in scRNA-seq","volume":"41","author":"Van Hecke M","year":"2025","unstructured":"Van Hecke M, Beerenwinkel N, Lootens T, Fostier J, Raedt R, Marchal K. ELLIPSIS: Robust quantification of splicing in scRNA-seq. Bioinformatics. 2025;41(2): Article btaf028.","journal-title":"Bioinformatics"},{"key":"e_1_3_2_302_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0178-8"},{"issue":"1","key":"e_1_3_2_303_2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031245","article-title":"Osteoimmunology","volume":"9","author":"Okamoto K","year":"2019","unstructured":"Okamoto K, Takayanagi H. Osteoimmunology. Cold Spring Harb Perspect Med. 2019;9(1): Article a031245.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"e_1_3_2_304_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-018-0071-5"},{"issue":"1","key":"e_1_3_2_305_2","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1038\/s41467-021-22444-1","article-title":"A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection","volume":"12","author":"Larson MH","year":"2021","unstructured":"Larson MH, Pan W, Kim HJ, Mauntz RE, Stuart SM, Pimentel M, Zhou Y, Knudsgaard P, Demas V, Aravanis AM, et al. A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection. Nat Commun. 2021;12(1):2357.","journal-title":"Nat Commun"},{"issue":"1","key":"e_1_3_2_306_2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13046-025-03279-w","article-title":"Targeting RNA splicing modulation: New perspectives for anticancer strategy?","volume":"44","author":"Lv X","year":"2025","unstructured":"Lv X, Sun X, Gao Y, Song X, Hu X, Gong L, Han L, He M, Wei M. Targeting RNA splicing modulation: New perspectives for anticancer strategy? J Exp Clin Cancer Res. 2025;44(1):32.","journal-title":"J Exp Clin Cancer Res"},{"key":"e_1_3_2_307_2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3389\/fgene.2020.00731","article-title":"Innovative therapeutic and delivery approaches using nanotechnology to correct splicing defects underlying disease","volume":"11","author":"Su\u00f1\u00e9-Pou M","year":"2020","unstructured":"Su\u00f1\u00e9-Pou M, Limeres MJ, Moreno-Castro C, Hern\u00e1ndez-Munain C, Su\u00f1\u00e9-Negre JM, Cuestas ML, Sune C. Innovative therapeutic and delivery approaches using nanotechnology to correct splicing defects underlying disease. Front Genet. 2020;11:731.","journal-title":"Front Genet"},{"key":"e_1_3_2_308_2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.868664","article-title":"Therapeutic targeting of alternative splicing: A new frontier in cancer treatment","volume":"12","author":"Murphy AJ","year":"2022","unstructured":"Murphy AJ, Li AH, Li P, Sun H. Therapeutic targeting of alternative splicing: A new frontier in cancer treatment. Front Oncol. 2022;12: Article 868664.","journal-title":"Front Oncol"},{"key":"e_1_3_2_309_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.12.022"},{"key":"e_1_3_2_310_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9062004"},{"key":"e_1_3_2_311_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2021.04.005"},{"key":"e_1_3_2_312_2","doi-asserted-by":"publisher","DOI":"10.1261\/rna.079585.123"},{"issue":"23","key":"e_1_3_2_313_2","doi-asserted-by":"crossref","first-page":"13121","DOI":"10.3390\/ijms252313121","article-title":"Overcoming challenges in small-molecule drug bioavailability: A review of key factors and approaches","volume":"25","author":"Wu K","year":"2024","unstructured":"Wu K, Kwon SH, Zhou X, Fuller C, Wang X, Vadgama J, Wu Y. Overcoming challenges in small-molecule drug bioavailability: A review of key factors and approaches. Int J Mol Sci. 2024;25(23):13121.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_2_314_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrg.2015.3"},{"issue":"4","key":"e_1_3_2_315_2","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1476","article-title":"Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics","volume":"9","author":"Urbanski LM","year":"2018","unstructured":"Urbanski LM, Leclair N, Anczuk\u00f3w O. Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics. Wiley Interdiscip Rev RNA. 2018;9(4): Article e1476.","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"1","key":"e_1_3_2_316_2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-022-00380-8","article-title":"Spinal muscular atrophy","volume":"8","author":"Mercuri E","year":"2022","unstructured":"Mercuri E, Sumner CJ, Muntoni F, Darras BT, Finkel RS. Spinal muscular atrophy. Nat Rev Dis Primers. 2022;8(1):52.","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"e_1_3_2_317_2","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s40263-021-00878-x","article-title":"Nusinersen: A review in 5q spinal muscular atrophy","volume":"35","author":"Hoy SM","year":"2021","unstructured":"Hoy SM. Nusinersen: A review in 5q spinal muscular atrophy. CNS Drugs. 2021;35(12):1317\u20131328.","journal-title":"CNS Drugs"},{"key":"e_1_3_2_318_2","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4508"},{"key":"e_1_3_2_319_2","doi-asserted-by":"crossref","DOI":"10.1177\/22143602251317422","article-title":"A historical perspective on the development of antisense oligonucleotide treatments for Duchenne muscular dystrophy and spinal muscular atrophy","author":"Aartsma-Rus A","year":"2025","unstructured":"Aartsma-Rus A, Takeda S. A historical perspective on the development of antisense oligonucleotide treatments for Duchenne muscular dystrophy and spinal muscular atrophy. J Neuromuscul Dis. 2025; 10.1177\/22143602251317422.","journal-title":"J Neuromuscul Dis"},{"issue":"4","key":"e_1_3_2_320_2","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","article-title":"Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice","volume":"82","author":"Hua Y","year":"2008","unstructured":"Hua Y, Vickers TA, Okunola HL, Bennett CF, Krainer AR. Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice. Am J Hum Genet. 2008;82(4):834\u2013848.","journal-title":"Am J Hum Genet"},{"issue":"18","key":"e_1_3_2_321_2","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel RS","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, Chiriboga AC, Saito K, Servais L, Tizzano E, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017;377(18):1723\u20131732.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_322_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2024.12.006"},{"issue":"10","key":"e_1_3_2_323_2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJMoa2009965","article-title":"Risdiplam in type 1 spinal muscular atrophy","volume":"384","author":"Baranello G","year":"2021","unstructured":"Baranello G, Darras BT, Day JW, Deconinck N, Klein A, Masson R, Mercuri E, Rose K, El-Khairi M, Gerber M, et al. Risdiplam in type 1 spinal muscular atrophy. N Engl J Med. 2021;384(10):915\u2013923.","journal-title":"N Engl J Med"},{"issue":"5","key":"e_1_3_2_324_2","doi-asserted-by":"crossref","DOI":"10.1002\/jssc.70173","article-title":"Short review on currently used sample preparation and determination methods of risdiplam","volume":"48","author":"Bali\u0144ska N","year":"2025","unstructured":"Bali\u0144ska N, Ostrowska K, Studzi\u0144ska S. Short review on currently used sample preparation and determination methods of risdiplam. J Sep Sci. 2025;48(5): Article e70173.","journal-title":"J Sep Sci"},{"issue":"12","key":"e_1_3_2_325_2","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S1474-4422(22)00339-8","article-title":"Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): Secondary analyses from an open-label trial","volume":"21","author":"Masson R","year":"2022","unstructured":"Masson R, Mazurkiewicz-Be\u0142dzi\u0144ska M, Rose K, Servais L, Xiong H, Zanoteli E, Baranello G, Bruno C, Day JW, Deconinck N, et al. Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): Secondary analyses from an open-label trial. Lancet Neurol. 2022;21(12):1110\u20131119.","journal-title":"Lancet Neurol"},{"issue":"5","key":"e_1_3_2_326_2","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1007\/s00415-023-11560-1","article-title":"Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA)","volume":"270","author":"Oskoui M","year":"2023","unstructured":"Oskoui M, Day JW, Deconinck N, Mazzone ES, Nascimento A, Saito K, Vuillerot C, Baranello G, Goemans N, Kirschner J, et al. Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA). J Neurol. 2023;270(5):2531\u20132546.","journal-title":"J Neurol"},{"key":"e_1_3_2_327_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00521-4"},{"issue":"1","key":"e_1_3_2_328_2","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/s41467-022-28653-6","article-title":"An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion","volume":"13","author":"Keller CG","year":"2022","unstructured":"Keller CG, Shin Y, Monteys AM, Renaud N, Beibel M, Teider N, Peters T, Faller T, St-Cyr S, Knehr J, et al. An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion. Nat Commun. 2022;13(1):1150.","journal-title":"Nat Commun"},{"issue":"1","key":"e_1_3_2_329_2","doi-asserted-by":"crossref","first-page":"8776","DOI":"10.1038\/s41467-024-53124-5","article-title":"A sequential binding mechanism for 5\u2019 splice site recognition and modulation for the human U1 snRNP","volume":"15","author":"White DS","year":"2024","unstructured":"White DS, Dunyak BM, Vaillancourt FH, Hoskins AA. A sequential binding mechanism for 5\u2019 splice site recognition and modulation for the human U1 snRNP. Nat Commun. 2024;15(1):8776.","journal-title":"Nat Commun"},{"issue":"3","key":"e_1_3_2_330_2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10637-013-0046-5","article-title":"A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors","volume":"32","author":"Hong DS","year":"2014","unstructured":"Hong DS, Kurzrock R, Naing A, Wheler JJ, Falchook GS, Schiffman JS, Faulkner N, Pilat MJ, O\u2019Brien J, LoRusso P. A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors. Investig New Drugs. 2014;32(3):436\u2013444.","journal-title":"Investig New Drugs"},{"issue":"8","key":"e_1_3_2_331_2","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.7150\/ijbs.92671","article-title":"Exploring splicing modulation as an innovative approach to combat pancreatic cancer: SF3B1 emerges as a prognostic indicator and therapeutic target","volume":"20","author":"Sciarrillo R","year":"2024","unstructured":"Sciarrillo R, Terrana F, Comandatore A, Supadmanaba IGP, Wang B, Hassouni BE, Mantini G, Jansen G, Avan A, Carbone D, et al. Exploring splicing modulation as an innovative approach to combat pancreatic cancer: SF3B1 emerges as a prognostic indicator and therapeutic target. Int J Biol Sci. 2024;20(8):3173\u20133184.","journal-title":"Int J Biol Sci"},{"key":"e_1_3_2_332_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.311043.117"},{"issue":"12","key":"e_1_3_2_333_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/iovs.65.12.11","article-title":"The impact of spliceosome inhibition in SF3B1-mutated uveal melanoma","volume":"65","author":"Nguyen JQN","year":"2024","unstructured":"Nguyen JQN, Drabarek W, Leeflang A, Brands T, van den Bosch TPP, Verdijk RM, van de Werken HJG, van Riet J, Paridaens D, de Klein A, et al. The impact of spliceosome inhibition in SF3B1-mutated uveal melanoma. Invest Ophthalmol Vis Sci. 2024;65(12):11.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"e_1_3_2_334_2","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1261\/rna.065383.117","article-title":"Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping","volume":"24","author":"Wu G","year":"2018","unstructured":"Wu G, Fan L, Edmonson MN, Shaw T, Boggs K, Easton J, Rusch MC, Webb TR, Zhang J, Potter PM. Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping. RNA. 2018;24(8):1056\u20131066.","journal-title":"RNA"},{"issue":"4","key":"e_1_3_2_335_2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nm.4493","article-title":"H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers","volume":"24","author":"Seiler M","year":"2018","unstructured":"Seiler M, Yoshimi A, Darman R, Chan B, Keaney G, Thomas M, Agrawal AA, Caleb B, Csibi A, Sean E, et al. H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers. Nat Med. 2018;24(4):497\u2013504.","journal-title":"Nat Med"},{"issue":"12","key":"e_1_3_2_336_2","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1038\/s41375-021-01328-9","article-title":"Phase I first-in-human dose escalation study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms","volume":"35","author":"Steensma DP","year":"2021","unstructured":"Steensma DP, Wermke M, Klimek VM, Greenberg PL, Font P, Komrokji RS, Yang J, Brunner AM, Carraway HE, Ades L, et al. Phase I first-in-human dose escalation study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms. Leukemia. 2021;35(12):3542\u20133550.","journal-title":"Leukemia"},{"issue":"4","key":"e_1_3_2_337_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108345","article-title":"PKM splice-switching ASOs induce upregulation of dual-specificity phosphatases and dephosphorylation of ERK1\/2 in hepatocellular carcinoma","volume":"301","author":"Voss DM","year":"2025","unstructured":"Voss DM, Kral AJ, Sim G, Utama R, Lin KT, Cizmeciyan C, Schafer B, Cunniff PJ, Vakoc CR, Caruthers MH, et al. PKM splice-switching ASOs induce upregulation of dual-specificity phosphatases and dephosphorylation of ERK1\/2 in hepatocellular carcinoma. J Biol Chem. 2025;301(4): Article 108345.","journal-title":"J Biol Chem"},{"issue":"1","key":"e_1_3_2_338_2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41413-025-00413-4","article-title":"SIRT3-PINK1-PKM2 axis prevents osteoarthritis via mitochondrial renewal and metabolic switch","volume":"13","author":"Deng Y","year":"2025","unstructured":"Deng Y, Hou M, Wu Y, Liu Y, Xia X, Yu C, Yu J, Yang H, Zhang Y, Zhu X. SIRT3-PINK1-PKM2 axis prevents osteoarthritis via mitochondrial renewal and metabolic switch. Bone Res. 2025;13(1):36.","journal-title":"Bone Res"},{"issue":"4","key":"e_1_3_2_339_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108389","article-title":"The glycolytic enzyme PKM2 regulates inflammatory osteoclastogenesis by modulating STAT3 phosphorylation","volume":"301","author":"Li M","year":"2025","unstructured":"Li M, Li F, Zhu C, Zhang C, Le Y, Li Z, Wang Q. The glycolytic enzyme PKM2 regulates inflammatory osteoclastogenesis by modulating STAT3 phosphorylation. J Biol Chem. 2025;301(4): Article 108389.","journal-title":"J Biol Chem"},{"issue":"4","key":"e_1_3_2_340_2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3892\/ijo.2022.5334","article-title":"LncCCAT1 interaction protein PKM2 upregulates SREBP2 phosphorylation to promote osteosarcoma tumorigenesis by enhancing the Warburg effect and lipogenesis","volume":"60","author":"Pu F","year":"2022","unstructured":"Pu F, Liu J, Jing D, Chen F, Huang X, Shi D, Wu W, Lin H, Zhao L, Zhang Z, et al. LncCCAT1 interaction protein PKM2 upregulates SREBP2 phosphorylation to promote osteosarcoma tumorigenesis by enhancing the Warburg effect and lipogenesis. Int J Oncol. 2022;60(4):44.","journal-title":"Int J Oncol"},{"key":"e_1_3_2_341_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-0948"},{"key":"e_1_3_2_342_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2021.07.019"},{"key":"e_1_3_2_343_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107859","article-title":"Medicinal chemistry insights into PRMT5 inhibitors","volume":"153","author":"Jiao Z","year":"2024","unstructured":"Jiao Z, Huang Y, Gong K, Liu Y, Sun J, Yu S, Zhao G. Medicinal chemistry insights into PRMT5 inhibitors. Bioorg Chem. 2024;153: Article 107859.","journal-title":"Bioorg Chem"},{"key":"e_1_3_2_344_2","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2019-130337","article-title":"A phase I\/II study to investigate the safety and clinical activity of the protein arginine methyltransferase 5 inhibitor GSK3326595 in subjects with myelodysplastic syndrome and acute myeloid leukemia","volume":"134","author":"Watts JM","year":"2019","unstructured":"Watts JM, Bradley TJ, Thomassen A, Brunner AM, Minden MD, Papadantonakis N, Abedin S, Baines AJ, Barbash O, Gorman S, et al. A phase I\/II study to investigate the safety and clinical activity of the protein arginine methyltransferase 5 inhibitor GSK3326595 in subjects with myelodysplastic syndrome and acute myeloid leukemia. Blood. 2019;134:2656.","journal-title":"Blood"},{"key":"e_1_3_2_345_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.07.003"},{"key":"e_1_3_2_346_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0887"},{"issue":"8","key":"e_1_3_2_347_2","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1158\/1538-7445.AM2025-4225","article-title":"Abstract 4225: Targeting RNA splicing sensitizes MTAP-deleted cancers to MTA-cooperative PRMT5 inhibitors","volume":"85","author":"Slemmons KK","year":"2025","unstructured":"Slemmons KK, Su C, Liu S, Yu P-W, McEntee M, Yuan E, Lee J, Lu J, Horning A, Hindoyan A, et al. Abstract 4225: Targeting RNA splicing sensitizes MTAP-deleted cancers to MTA-cooperative PRMT5 inhibitors. Cancer Res. 2025;85(8_Supplement_1):4225.","journal-title":"Cancer Res"},{"key":"e_1_3_2_348_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.08.002"},{"key":"e_1_3_2_349_2","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-23-0070"},{"issue":"1","key":"e_1_3_2_350_2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1186\/s12885-023-11260-z","article-title":"Inhibiting PRMT5 induces DNA damage and increases anti-proliferative activity of Niraparib, a PARP inhibitor, in models of breast and ovarian cancer","volume":"23","author":"O\u2019Brien S","year":"2023","unstructured":"O\u2019Brien S, Butticello M, Thompson C, Wilson B, Wyce A, Mahajan V, Kruger R, Mohammad H, Fedoriw A. Inhibiting PRMT5 induces DNA damage and increases anti-proliferative activity of Niraparib, a PARP inhibitor, in models of breast and ovarian cancer. BMC Cancer. 2023;23(1):775.","journal-title":"BMC Cancer"},{"key":"e_1_3_2_351_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2018.08.025"},{"key":"e_1_3_2_352_2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cellsig.2017.03.004","article-title":"Inhibition of PRMT5 suppresses osteoclast differentiation and partially protects against ovariectomy-induced bone loss through downregulation of CXCL10 and RSAD2","volume":"34","author":"Dong Y","year":"2017","unstructured":"Dong Y, Song C, Wang Y, Lei Z, Xu F, Guan H, Chen A, Li F. Inhibition of PRMT5 suppresses osteoclast differentiation and partially protects against ovariectomy-induced bone loss through downregulation of CXCL10 and RSAD2. Cell Signal. 2017;34:55\u201365.","journal-title":"Cell Signal"},{"key":"e_1_3_2_353_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2019.08.012"},{"issue":"11","key":"e_1_3_2_354_2","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1158\/2767-9764.CRC-23-0239","article-title":"Antitumor effects of PRMT5 inhibition in sarcomas","volume":"3","author":"Verbeke S","year":"2023","unstructured":"Verbeke S, Bourdon A, Guegan JP, Leroy L, Chaire V, Richard E, Bessede A, Italiano A. Antitumor effects of PRMT5 inhibition in sarcomas. Cancer Res Commun. 2023;3(11):2211\u20132220.","journal-title":"Cancer Res Commun"},{"issue":"8","key":"e_1_3_2_355_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41389-020-00263-1","article-title":"LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1","volume":"9","author":"Malvi P","year":"2020","unstructured":"Malvi P, Janostiak R, Chava S, Manrai P, Yoon E, Singh K, Harigopal M, Gupta R, Wajapeyee N. LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1. Oncogene. 2020;9(8):77.","journal-title":"Oncogene"},{"issue":"1","key":"e_1_3_2_356_2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s42003-020-0983-4","article-title":"SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells","volume":"3","author":"Wang C","year":"2020","unstructured":"Wang C, Zhou Z, Subhramanyam CS, Cao Q, Heng ZSL, Liu W, Fu X, Hu Q. SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells. Commun Biol. 2020;3(1):268.","journal-title":"Commun Biol"},{"key":"e_1_3_2_357_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02645-2"},{"issue":"12","key":"e_1_3_2_358_2","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1158\/0008-5472.CAN-08-0021","article-title":"Serine\/arginine protein-specific kinase 2 promotes leukemia cell proliferation by phosphorylating acinus and regulating cyclin A1","volume":"68","author":"Jang SW","year":"2008","unstructured":"Jang SW, Yang SJ, Ehl\u00e9n A, Dong S, Khoury H, Chen J, Persson JL, Ye K. Serine\/arginine protein-specific kinase 2 promotes leukemia cell proliferation by phosphorylating acinus and regulating cyclin A1. Cancer Res. 2008;68(12):4559\u20134570.","journal-title":"Cancer Res"},{"issue":"8","key":"e_1_3_2_359_2","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1007\/s13277-015-3289-2","article-title":"The influence of SRPK1 on glioma apoptosis, metastasis, and angiogenesis through the PI3K\/Akt signaling pathway under normoxia","volume":"36","author":"Chang Y","year":"2015","unstructured":"Chang Y, Wu Q, Tian T, Li L, Guo X, Feng Z, Zhou J, Zhang L, Zhou S, Feng G, et al. The influence of SRPK1 on glioma apoptosis, metastasis, and angiogenesis through the PI3K\/Akt signaling pathway under normoxia. Tumour Biol. 2015;36(8):6083\u20136093.","journal-title":"Tumour Biol"},{"issue":"1","key":"e_1_3_2_360_2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s42004-024-01230-2","article-title":"Design of a covalent protein-protein interaction inhibitor of SRPKs to suppress angiogenesis and invasion of cancer cells","volume":"7","author":"Cai G","year":"2024","unstructured":"Cai G, Bao Y, Li Q, Hsu PH, Xia J, Ngo JCK. Design of a covalent protein-protein interaction inhibitor of SRPKs to suppress angiogenesis and invasion of cancer cells. Commun Chem. 2024;7(1):144.","journal-title":"Commun Chem"},{"issue":"5","key":"e_1_3_2_361_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102423","article-title":"Protein-protein interaction inhibitor of SRPKs alters the splicing isoforms of VEGF and inhibits angiogenesis","volume":"24","author":"Li Q","year":"2021","unstructured":"Li Q, Zeng C, Liu H, Yung KWY, Chen C, Xie Q, Zhang Y, Wan SWC, Mak BSW, Xia J, et al. Protein-protein interaction inhibitor of SRPKs alters the splicing isoforms of VEGF and inhibits angiogenesis. iScience. 2021;24(5): Article 102423.","journal-title":"iScience"},{"issue":"6","key":"e_1_3_2_362_2","doi-asserted-by":"crossref","first-page":"H1014","DOI":"10.1152\/ajpheart.00001.2022","article-title":"Serine-arginine-rich protein kinase-1 inhibition for the treatment of diabetic retinopathy","volume":"322","author":"Malhi NK","year":"2022","unstructured":"Malhi NK, Allen CL, Stewart E, Horton KL, Riu F, Batson J, Amoaku W, Morris JC, Arkilll KP, Bates DO. Serine-arginine-rich protein kinase-1 inhibition for the treatment of diabetic retinopathy. Am J Physiol Heart Circ Physiol. 2022;322(6):H1014\u2013h27.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"e_1_3_2_363_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105385","article-title":"Inhibition of serine\/arginine-rich protein kinase-1 (SRPK1) prevents cholangiocarcinoma cells induced angiogenesis","volume":"82","author":"Supradit K","year":"2022","unstructured":"Supradit K, Boonsri B, Duangdara J, Thitiphatphuvanon T, Suriyonplengsaeng C, Kangsamaksin T, Janvilisri T, Tohtong R, Yacqub-Usman K, Grabowska AM, et al. Inhibition of serine\/arginine-rich protein kinase-1 (SRPK1) prevents cholangiocarcinoma cells induced angiogenesis. Toxicol In\u00a0Vitro. 2022;82: Article 105385.","journal-title":"Toxicol In\u00a0Vitro"},{"key":"e_1_3_2_364_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2018.1427068"},{"issue":"12","key":"e_1_3_2_365_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190251","article-title":"Serum N-propeptide of collagen IIA (PIIANP) as a marker of radiographic osteoarthritis burden","volume":"12","author":"Daghestani HN","year":"2017","unstructured":"Daghestani HN, Jordan JM, Renner JB, Doherty M, Wilson AG, Kraus VB. Serum N-propeptide of collagen IIA (PIIANP) as a marker of radiographic osteoarthritis burden. PLOS ONE. 2017;12(12): Article e0190251.","journal-title":"PLOS ONE"},{"issue":"1","key":"e_1_3_2_366_2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13018-018-0840-z","article-title":"Serum levels of PIICP, PIIANP, and PIIBNP are decreased in patients with an endemic osteochondropathy, Kashin-Beck disease","volume":"13","author":"Lian W","year":"2018","unstructured":"Lian W, Liu H, Sun LY, Liu YQ, Cui SL, Wang Y, Song QQ, Deng Q, Wang SP, Cao YH, et al. Serum levels of PIICP, PIIANP, and PIIBNP are decreased in patients with an endemic osteochondropathy, Kashin-Beck disease. J Orthop Surg Res. 2018;13(1):128.","journal-title":"J Orthop Surg Res"},{"key":"e_1_3_2_367_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2021.04.019"},{"key":"e_1_3_2_368_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.824117","article-title":"Roles of the RANKL-RANK axis in immunity\u2014Implications for pathogenesis and treatment of bone metastasis","volume":"13","author":"Li B","year":"2022","unstructured":"Li B, Wang P, Jiao J, Wei H, Xu W, Zhou P. Roles of the RANKL-RANK axis in immunity\u2014Implications for pathogenesis and treatment of bone metastasis. Front Immunol. 2022;13: Article 824117.","journal-title":"Front Immunol"},{"issue":"5","key":"e_1_3_2_369_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101807","article-title":"An miRNA derived from amelogenin exon4 regulates expression of transcription factor Runx2 by directly targeting upstream activators Nfia and Prkch","volume":"298","author":"Shemirani R","year":"2022","unstructured":"Shemirani R, Lin G, Abduweli Uyghurturk D, Le M, Nakano Y. An miRNA derived from amelogenin exon4 regulates expression of transcription factor Runx2 by directly targeting upstream activators Nfia and Prkch. J Biol Chem. 2022;298(5): Article 101807.","journal-title":"J Biol Chem"},{"key":"e_1_3_2_370_2","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.04986","article-title":"Crystal structure of human U1 snRNP, a small nuclear ribonucleoprotein particle, reveals the mechanism of 5\u2032 splice site recognition","volume":"4","author":"Kondo Y","year":"2015","unstructured":"Kondo Y, Oubridge C, van Roon A-MM, Nagai K. Crystal structure of human U1 snRNP, a small nuclear ribonucleoprotein particle, reveals the mechanism of 5\u2032 splice site recognition. eLife. 2015;4: Article e04986.","journal-title":"eLife"},{"key":"e_1_3_2_371_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2009.00863.x"},{"issue":"5","key":"e_1_3_2_372_2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/10409238.2019.1691497","article-title":"Structural and functional modularity of the U2 snRNP in pre-mRNA splicing","volume":"54","author":"Feltz C","year":"2019","unstructured":"van der Feltz C, Hoskins AA. Structural and functional modularity of the U2 snRNP in pre-mRNA splicing. Crit Rev Biochem Mol Biol. 2019;54(5):443\u2013465.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"e_1_3_2_373_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab695"},{"key":"e_1_3_2_374_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09956"},{"key":"e_1_3_2_375_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(00)00131-3"},{"key":"e_1_3_2_376_2","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.636620","article-title":"The role of the U5 snRNP in genetic disorders and cancer","volume":"12","author":"Wood KA","year":"2021","unstructured":"Wood KA, Eadsforth MA, Newman WG, O\u2019Keefe RT. The role of the U5 snRNP in genetic disorders and cancer. Front Genet. 2021;12: Article 636620.","journal-title":"Front Genet"},{"issue":"19","key":"e_1_3_2_377_2","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1093\/emboj\/16.19.5797","article-title":"The role of U5 snRNP in pre-mRNA splicing","volume":"16","author":"Newman AJ","year":"1997","unstructured":"Newman AJ. The role of U5 snRNP in pre-mRNA splicing. EMBO J. 1997;16(19):5797\u20135800.","journal-title":"EMBO J"},{"issue":"5","key":"e_1_3_2_378_2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/wrna.1181","article-title":"U6 RNA biogenesis and disease association","volume":"4","author":"Mroczek S","year":"2013","unstructured":"Mroczek S, Dziembowski A. U6 RNA biogenesis and disease association. Wiley Interdiscip Rev RNA. 2013;4(5):581\u2013592.","journal-title":"Wiley Interdiscip Rev RNA."},{"issue":"1","key":"e_1_3_2_379_2","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/s41467-018-04145-4","article-title":"Architecture of the U6 snRNP reveals specific recognition of 3\u2019-end processed U6 snRNA","volume":"9","author":"Montemayor EJ","year":"2018","unstructured":"Montemayor EJ, Didychuk AL, Yake AD, Sidhu GK, Brow DA, Butcher SE. Architecture of the U6 snRNP reveals specific recognition of 3\u2019-end processed U6 snRNA. Nat Commun. 2018;9(1):1749.","journal-title":"Nat Commun"},{"key":"e_1_3_2_380_2","doi-asserted-by":"publisher","DOI":"10.1042\/BST0381099"},{"key":"e_1_3_2_381_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200210087"},{"key":"e_1_3_2_382_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2025.113864","article-title":"Inhibition of RANKL is critical for accurate assessment of anti-drug antibody incidence to denosumab in clinical studies","volume":"540","author":"Miller MJ","year":"2025","unstructured":"Miller MJ, Kroenke MA, Barger T, Manning MS, Sohn W, Graham K, Mytych DT, Gupta S. Inhibition of RANKL is critical for accurate assessment of anti-drug antibody incidence to denosumab in clinical studies. J Immunol Methods. 2025;540: Article 113864.","journal-title":"J Immunol Methods"},{"issue":"2","key":"e_1_3_2_383_2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40266-018-0525-7","article-title":"Denosumab: A review in postmenopausal osteoporosis","volume":"35","author":"Deeks ED","year":"2018","unstructured":"Deeks ED. Denosumab: A review in postmenopausal osteoporosis. Drugs Aging. 2018;35(2):163\u2013173.","journal-title":"Drugs Aging"},{"issue":"1","key":"e_1_3_2_384_2","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1038\/s41467-021-24741-1","article-title":"Structural basis of intron selection by U2 snRNP in the presence of covalent inhibitors","volume":"12","author":"Cretu C","year":"2021","unstructured":"Cretu C, Gee P, Liu X, Agrawal A, Nguyen TV, Ghosh AK, Cook A, Jurica M, Larsen NA, Pena V. Structural basis of intron selection by U2 snRNP in the presence of covalent inhibitors. Nat Commun. 2021;12(1):4491.","journal-title":"Nat Commun"},{"issue":"728","key":"e_1_3_2_385_2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade2774","article-title":"Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML","volume":"16","author":"Wheeler EC","year":"2024","unstructured":"Wheeler EC, Martin BJE, Doyle WC, Neaher S, Conway CA, Pitton CN, Gorelov RA, Donahue M, Jann JC, Abdel-Wahab O, et al. Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML. Sci Transl Med. 2024;16(728): Article eade2774.","journal-title":"Sci Transl Med"}],"container-title":["Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.34133\/research.0977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T08:01:57Z","timestamp":1763539317000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.34133\/research.0977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":384,"alternative-id":["10.34133\/research.0977"],"URL":"https:\/\/doi.org\/10.34133\/research.0977","relation":{},"ISSN":["2639-5274"],"issn-type":[{"value":"2639-5274","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2025-07-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"0977"}}